<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Phytother Res</journal-id><journal-id journal-id-type="iso-abbrev">Phytother Res</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1099-1573</journal-id><journal-id journal-id-type="publisher-id">PTR</journal-id><journal-title-group><journal-title>Phytotherapy Research</journal-title></journal-title-group><issn pub-type="ppub">0951-418X</issn><issn pub-type="epub">1099-1573</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Ltd.</publisher-name><publisher-loc>Chichester, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7675695</article-id><article-id pub-id-type="pmid">33037698</article-id><article-id pub-id-type="doi">10.1002/ptr.6893</article-id><article-id pub-id-type="publisher-id">PTR6893</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Potential roles of medicinal plants for the treatment of viral diseases focusing on <styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19: A review</article-title><alt-title alt-title-type="left-running-head">Adhikari et al.</alt-title></title-group><contrib-group><contrib id="ptr6893-cr-0001" contrib-type="author"><name><surname>Adhikari</surname><given-names>Bikash</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5532-6644</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6893-cr-0002" contrib-type="author"><name><surname>Marasini</surname><given-names>Bishnu P.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6153-5234</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ptr6893-cr-0003" contrib-type="author"><name><surname>Rayamajhee</surname><given-names>Binod</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3007-8901</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="ptr6893-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="ptr6893-cr-0004" contrib-type="author"><name><surname>Bhattarai</surname><given-names>Bibek Raj</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0259-5004</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6893-cr-0005" contrib-type="author"><name><surname>Lamichhane</surname><given-names>Ganesh</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4352-7457</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6893-cr-0006" contrib-type="author"><name><surname>Khadayat</surname><given-names>Karan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8125-9756</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="ptr6893-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ptr6893-cr-0007" contrib-type="author"><name><surname>Adhikari</surname><given-names>Achyut</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1065-5727</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ptr6893-cr-0008" contrib-type="author"><name><surname>Khanal</surname><given-names>Santosh</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0186-6119</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ptr6893-cr-0009" contrib-type="author" corresp="yes"><name><surname>Parajuli</surname><given-names>Niranjan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9233-6489</contrib-id><xref ref-type="aff" rid="ptr6893-aff-0001">
<sup>1</sup>
</xref><address><email>nparajuli@cdctu.edu.np</email></address></contrib></contrib-group><aff id="ptr6893-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Central Department of Chemistry</named-content>
<institution>Tribhuvan University</institution>
<city>Kirtipur</city>
<country country="NP">Nepal</country>
</aff><aff id="ptr6893-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Biotechnology, National College</named-content>
<institution>Tribhuvan University</institution>
<city>Kirtipur</city>
<country country="NP">Nepal</country>
</aff><aff id="ptr6893-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">School of Optometry and Vision Science, Faculty of Science</named-content>
<institution>University of New South Wales (UNSW)</institution>
<city>Sydney</city>
<country country="NP">Australia</country>
</aff><aff id="ptr6893-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Infection and Immunology</named-content>
<institution>Kathmandu Research Institute for Biological Sciences (KRIBS)</institution>
<city>Lalitpur</city>
<country country="NP">Nepal</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Niranjan Parajuli, Central Department of Chemistry, Tribhuvan University, Kirtipur, Kathmandu, Nepal.<break/>
Email: <email>nparajuli@cdctu.edu.np</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>10</month><year>2020</year></pub-date><elocation-id>10.1002/ptr.6893</elocation-id><history><date date-type="received"><day>15</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>16</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 John Wiley & Sons, Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 John Wiley &#x00026; Sons Ltd</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PTR-9999-na.pdf"/><abstract><p>The whole world is entangled by the coronavirus disease (COVID&#x02010;19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2), people are dying in thousands each day, and without an actual medication, it seems not possible for the bringing this global health crisis to a stop. Natural products have been in constant use since ancient times and are proven by time to be effective. Crude extract or pure compounds isolated from medicinal plants and/or herbs such as <italic>Artemisia annua</italic>, <italic>Agastache rugosa, Astragalus membranaceus, Cassia alata, Ecklonia cava, Gymnema sylvestre, Glycyrrhizae uralensis, Houttuynia cordata, Lindera aggregata</italic>, <italic>Lycoris radiata, Mollugo cerviana, Polygonum multiflorum, Pyrrosia lingua</italic>, <italic>Saposhnikoviae divaricate, Tinospora cordifolia</italic> etc. have shown promising inhibitory effect against coronavirus. Several molecules, including acacetin, amentoflavone, allicin, blancoxanthone, curcumin, daidzein, diosmin, epigallocatechin&#x02010;gallate, emodin, hesperidin, herbacetin, hirsutenone, iguesterin, jubanine G, kaempferol, lycorine, pectolinarin, phloroeckol, silvestrol, tanshinone I, taxifolin, rhoifolin, xanthoangelol E, zingerol etc. isolated from plants could also be potential drug candidates against COVID&#x02010;19. Moreover, these could also show promising inhibitory effects against influenza&#x02010;parainfluenza viruses, respiratory syncytial virus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV). Here, we have reported 93 antiviral drug candidates which could be a potential area of research in drug discovery.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ptr6893-kwd-0001">anti&#x02010;antiviral activity and COVID&#x02010;19</kwd><kwd id="ptr6893-kwd-0002">drug candidates</kwd><kwd id="ptr6893-kwd-0003">natural products</kwd></kwd-group><counts><fig-count count="2"/><table-count count="1"/><page-count count="15"/><word-count count="8453"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.4 mode:remove_FC converted:19.11.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="ptr6893-cit-9001">
<string-name>
<surname>Adhikari</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Marasini</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Rayamajhee</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Potential roles of medicinal plants for the treatment of viral diseases focusing on <styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19: A review</article-title>. <source xml:lang="en">Phytotherapy Research</source>. <year>2020</year>;<fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.6893</pub-id>
</mixed-citation>
</p></notes></front><body id="ptr6893-body-0001"><def-list list-content="abbreviations" id="ptr6893-lp-0001"><title>Abbreviations</title><def-item><term id="ptr6893-li-0001">ACE&#x02010;2</term><def id="ptr6893-li-0002"><p>Angiotensin&#x02010;converting enzyme&#x02010;2</p></def></def-item><def-item><term id="ptr6893-li-0003">ADV</term><def id="ptr6893-li-0004"><p>Adenovirus</p></def></def-item><def-item><term id="ptr6893-li-0005">AIDS</term><def id="ptr6893-li-0006"><p>Acquired immune deficiency syndrome</p></def></def-item><def-item><term id="ptr6893-li-0007">CHIKV</term><def id="ptr6893-li-0008"><p>Chikungunya virus</p></def></def-item><def-item><term id="ptr6893-li-0009">COVID&#x02010;19</term><def id="ptr6893-li-0010"><p>Coronavirus disease 2019</p></def></def-item><def-item><term id="ptr6893-li-0011">CPE</term><def id="ptr6893-li-0012"><p>Cytopathic effects</p></def></def-item><def-item><term id="ptr6893-li-0013">DENV&#x02010;1</term><def id="ptr6893-li-0014"><p>Dengue virus serotype 1</p></def></def-item><def-item><term id="ptr6893-li-0015">FACS</term><def id="ptr6893-li-0016"><p>Fluorescence&#x02010;activated cell sorting</p></def></def-item><def-item><term id="ptr6893-li-0017">HBV</term><def id="ptr6893-li-0018"><p>Hepatitis&#x02010;B virus</p></def></def-item><def-item><term id="ptr6893-li-0019">HCMV</term><def id="ptr6893-li-0020"><p>Human cytomegalovirus</p></def></def-item><def-item><term id="ptr6893-li-0021">HCV</term><def id="ptr6893-li-0022"><p>Hepatitis&#x02010;C virus</p></def></def-item><def-item><term id="ptr6893-li-0023">HIV</term><def id="ptr6893-li-0024"><p>Human immunodeficiency virus</p></def></def-item><def-item><term id="ptr6893-li-0025">HSV</term><def id="ptr6893-li-0026"><p>Herpes simplex virus</p></def></def-item><def-item><term id="ptr6893-li-0027">IVC</term><def id="ptr6893-li-0028"><p>in vitro compartmentalization</p></def></def-item><def-item><term id="ptr6893-li-0029">MERS</term><def id="ptr6893-li-0030"><p>Middle East respiratory syndrome</p></def></def-item><def-item><term id="ptr6893-li-0031">MERS&#x02010;CoVs</term><def id="ptr6893-li-0032"><p>Middle East respiratory syndrome coronavirus</p></def></def-item><def-item><term id="ptr6893-li-0033">RBD</term><def id="ptr6893-li-0034"><p>Receptor binding domain</p></def></def-item><def-item><term id="ptr6893-li-0035">RdRP</term><def id="ptr6893-li-0036"><p>RNA&#x02010;dependent RNA polymerase</p></def></def-item><def-item><term id="ptr6893-li-0037">RNA</term><def id="ptr6893-li-0038"><p>Ribonucleic acid</p></def></def-item><def-item><term id="ptr6893-li-0039">RSV</term><def id="ptr6893-li-0040"><p>Respiratory syncytial virus</p></def></def-item><def-item><term id="ptr6893-li-0041">SARS&#x02010;CoVs</term><def id="ptr6893-li-0042"><p>Severe acute respiratory syndrome coronaviruses</p></def></def-item><def-item><term id="ptr6893-li-0043">SI</term><def id="ptr6893-li-0044"><p>Selectivity index</p></def></def-item><def-item><term id="ptr6893-li-0045">uHTS</term><def id="ptr6893-li-0046"><p>ultra&#x02010;High&#x02010;throughput screening</p></def></def-item></def-list><sec id="ptr6893-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Coronaviruses are the infectious agents of respiratory tract infections but can also affect the digestive tract and systemically infect both humans and animals (Malik et al., <xref rid="ptr6893-bib-0044" ref-type="ref">2020</xref>). Coronaviruses are single&#x02010;stranded RNA viruses, which are highly diverse and first reported in 1960. Primarily, Coronavirus strains reside in bats and wild birds and can spread to other living beings. The first case of COVID&#x02010;19 was reported in Wuhan, China, on December 31, 2019, sometime later, Thailand reported the first case of the disease outside of Mainland China on January 13, 2020 (Hui et al., <xref rid="ptr6893-bib-0024" ref-type="ref">2020</xref>). The virus that causes COVID&#x02010;19 is believed to have originated in bats and then spread to humans, possibly through snakes and pangolins, perhaps by contamination of meat from wild animals and seafood, in meat and seafood markets in China. At present, about 210 countries and territories around the world are affected by COVID&#x02010;19. Notably, China, the USA, the UK, Spain, France, and Italy are the most severed because of COVID&#x02010;19. As of July 15, 2020, this pandemic has claimed the lives of 586,194 along with 13,683,743 confirmed cases (John Hopkins University, Coronavirus Resource Center). Common symptoms of COVID&#x02010;19 include fever, cough, shortness of breath, and diarrhea, but in severe cases, it may cause pneumonia and/or even death (WHO, <xref rid="ptr6893-bib-0073" ref-type="ref">2020a</xref>). The incubation period maybe 14&#x02009;days or even longer; the disease may still be infectious up to this latent period and can spread from one person to another via respiratory droplets, close contact, and also via the fomites (CDC, <xref rid="ptr6893-bib-0011" ref-type="ref">2020</xref>; WHO, <xref rid="ptr6893-bib-0074" ref-type="ref">2020b</xref>).</p><p>SARS&#x02010;CoV&#x02010;2 is a positive&#x02010;sense, single&#x02010;stranded RNA beta&#x02010;coronavirus with ~28,882 base pairs genome that encodes viral proteins in up to 14 open reading frames (Orfs) (Malik et al., <xref rid="ptr6893-bib-0044" ref-type="ref">2020</xref>). There are four major viral structural proteins: Spike (S), Envelope (E), Membrane (M), and Nucleocapsid (N). Structural proteins of SARS&#x02010;CoV&#x02010;2 form the viral capsid that encapsulates the genome and also facilitates the entry process to human cells through the ACE&#x02010;2 receptor (Figure 1S in <xref rid="ptr6893-supitem-0001" ref-type="supplementary-material">Data S1</xref>). Newly emerging viral borne infectious diseases have defied even the survival of humans and other living creatures. Usually, viral diseases are difficult to control and have a more comprehensive public health impact, so viral pathogens like HIV, human influenza, SARS, chikungunya, Ebola, Zika have received more attention and have threatened modern healthcare and pharmaceutical sectors. Many infections and abnormal physiology caused by several viruses belonging to coronavirideae family been reported (Table 1S in <xref rid="ptr6893-supitem-0001" ref-type="supplementary-material">Data S1</xref>).</p><p>Till now, there are no absolute therapies for COVID&#x02010;19, but preventive and supportive therapies are employed to control further complications and organ damage (Rodr&#x000ed;guez&#x02010;Morales, MacGregor, Kanagarajah, Patel, &#x00026; Schlagenhauf, <xref rid="ptr6893-bib-0063" ref-type="ref">2020</xref>). Based on the information available key regions of new drug targets are RNA&#x02010;dependent RNA polymerase (RdRP) of the virus, cell membrane receptors of SARS&#x02010;CoV&#x02010;2 (ACE&#x02010;2), and spike proteins (S protein), the antiviral mechanism of plant extracts varies as per the structure and replication process of the viruses. Some plants help to increase the inherent antiviral immunity of our body (Webster, Taschereau, Lee, &#x00026; Jurgens, <xref rid="ptr6893-bib-0072" ref-type="ref">2006</xref>). Some of the studies have already proven that plant extracts can be used for the preparation of peptides/proteins with the medicinal value, which can be a good source of vaccines and protein/peptides&#x02010;based treatment. However, screening of new therapeutic products will take an extended period, and medicinal plants could be an alternative, which is already tested by various ethnic groups since the ancient period. It is believed that medicinal plants are the primary source of healthcare for nearly 85% of the global population (Pe&#x00161;i&#x00107;, <xref rid="ptr6893-bib-0057" ref-type="ref">2015</xref>), and more than 40% of synthetic drugs available in pharmaceutical markets are derived from plants and microbial&#x02010;based natural products (Bauer &#x00026; Br&#x000f6;nstrup, <xref rid="ptr6893-bib-0006" ref-type="ref">2014</xref>). In order to find the potent antiviral drug of the COVID&#x02010;19, research should be directed to emulsion&#x02010;based uHTS as well for the screening of hundreds of natural products. Thus, this review is focused on summarizing medicinal plants and/or herbs showing antiviral properties, which could be useful in drug discovery programs.</p></sec><sec id="ptr6893-sec-0002"><label>2</label><title>CURRENT TREATMENT APPROACHES FOR VIRAL INFECTIONS</title><p>The era of antiviral drug development was begun after the approval of idoxuridine in June 1963, which was the first anti&#x02010;herpes antiviral drug that inhibits viral DNA synthesis (De Clercq, <xref rid="ptr6893-bib-0016" ref-type="ref">2004</xref>). Since then, more than 90 drugs of different functional groups have been authorized for the therapeutic purpose of viral diseases, including HIV, HBV, HCV, and influenza virus infections (De Clercq &#x00026; Li, <xref rid="ptr6893-bib-0017" ref-type="ref">2016</xref>). On the other hand, increasing antiviral drug resistance (ADR) like in herpesviruses and HBV is a pressing concern, and ADR could be managed by understanding the mechanism of resistance pattern, formulation of new drugs, optimization of compound delivery, and host components (Manuscript &#x00026; Implications, ). High costs and adverse side effects of synthetic drugs, along with the emergence of ADR has demanded the safe and novel antiviral drugs. Herbal extracts have become an exceptional alternative for the formulation of antiviral drugs that can inhibit multiple steps of the virus replication cycle. Furthermore, plant&#x02010;based antiviral compounds have shown remarkable results even in multiple clinical trials; for instance, anthocyanins (Pour, Fakhri, Asgary, Farzaei, &#x00026; Echeverr&#x000ed;a, <xref rid="ptr6893-bib-0058" ref-type="ref">2019</xref>).</p><p>Medicinal plants were investigated for antiviral activity against the different human viruses like HIV, HSV, rabies virus, SARS, MERS, poxvirus, dengue virus, and influenza viruses (Table 2S in <xref rid="ptr6893-supitem-0001" ref-type="supplementary-material">Data S1</xref>). <italic>Nepeta nepetella</italic> (150&#x02013;500&#x02009;&#x003bc;g/ml), <italic>Nepeta coerulea</italic> (150&#x02013;500&#x02009;&#x003bc;g/ml), <italic>Nepeta tuberosa</italic> (150&#x02013;500&#x02009;&#x003bc;g/ml), <italic>Dittrichia viscosa</italic> (50&#x02013;125&#x02009;&#x003bc;g/ml), and <italic>Sanguisorba minor magnolii</italic> (50&#x02013;125&#x02009;&#x003bc;g/ml), showed an explicit antiviral activity against two different DNA and RNA viruses, that is, HSV&#x02010;1 and vesicular stomatitis virus (VSV) (Abad, Guerra, Bermejo, Irurzun, &#x00026; Carrasco, <xref rid="ptr6893-bib-0001" ref-type="ref">2000</xref>). <italic>Eleutherococcus senticosus</italic> roots extract inhibited the replication of RNA viruses such as human rotavirus, RSV, and influenza A virus, but failed to inhibit DNA viruses such as adenovirus and HSV (Glatthaar&#x02010;Saalm&#x000fc;ller, Sacher, &#x00026; Esperester, <xref rid="ptr6893-bib-0021" ref-type="ref">2001</xref>). <italic>Azardirachta indica</italic> inhibited HSV&#x02010;1 infection by blocking the entry of the virus to the receptor (glycoprotein) (Tiwari, Darmani, Yue, &#x00026; Shukla, <xref rid="ptr6893-bib-0068" ref-type="ref">2010</xref>). The extracts of <italic>Cotoneaster integrifolius</italic> and <italic>Clinopodium umbrosum</italic>, and of <italic>Abies spectabilis</italic> and <italic>Valeriana jatamansi</italic> showed moderate activity (IC<sub>50</sub> =&#x02009;16&#x02013;20&#x02009;&#x003bc;g/ml) against HSV&#x02010;1 and H1N1, respectively (Rajbhandari, Wegner, J&#x000fc;lich, Sch&#x000f6;pke, &#x00026; Mentel, <xref rid="ptr6893-bib-0060" ref-type="ref">2001</xref>). <italic>Macaranga barteri</italic> leaves extract showed antiviral activity with IC<sub>50</sub> of 0.028 and 0.00017&#x02009;ng/ml against echovirus E7 and E19, respectively (Ogbole, Akinleye, Segun, Faleye, &#x00026; Adeniji, <xref rid="ptr6893-bib-0052" ref-type="ref">2018</xref>). Similarly, <italic>Ampelocissus tomentosa</italic> (EC<sub>50</sub> =&#x02009;7.79&#x02009;&#x003bc;g/ml), <italic>Kalanchoe pinnata</italic> (EC<sub>50</sub> =&#x02009;6.1 &#x003bc;g/ml) and <italic>Paris polyphylla</italic> (EC<sub>50</sub> =&#x02009;8.74&#x02009;&#x003bc;g/ml) were active against CHIKV while <italic>Clerodendrum serratum</italic> (EC<sub>50</sub> =&#x02009;15.9 &#x003bc;g/ml) and <italic>Terminalia chebula</italic> (EC<sub>50</sub> =&#x02009;10.6 &#x003bc;g/ml) were active against yellow fever virus and enterovirus A71, respectively (Joshi et al., <xref rid="ptr6893-bib-0030" ref-type="ref">2020</xref>). <italic>Amomurn villosum</italic> Lour, <italic>Melaphis chinensis</italic> (Bell) Baker, <italic>Sanguisorba officinalis</italic>, and <italic>Flos caryophylli</italic> extracts showed potent inhibitory activity against Neuraminidase (NA) with IC<sub>50</sub> ranging from 4.1 to 9. 6&#x02009;&#x003bc;g/ml (J. Liu et al., <xref rid="ptr6893-bib-0040" ref-type="ref">2018</xref>).</p><p>
<italic>Gymnema sylvestre</italic> R. Br., <italic>Pergularia daemia</italic> (Forsskal) Chiov., <italic>Cassia alata</italic> L., <italic>Sphaeranthus indicus</italic> L., <italic>Evolvulus alsinoides</italic> L., <italic>Clitoria ternatea</italic> L., <italic>Indigofera tinctoria</italic> L., <italic>Vitex trifolia</italic> L., <italic>Clerodendrum inerme</italic> (L.) Gaertn, <italic>Abutilon indicum</italic> G. Don., and <italic>Leucas aspera</italic> Spr. exhibited anti&#x02010;mouse coronavirus (MCV, human SARS surrogate) and anti&#x02010;HSV activity at a concentration of 0.4 &#x003bc;g/ml (Vimalanathan, Ignacimuthu, &#x00026; Hudson, <xref rid="ptr6893-bib-0071" ref-type="ref">2009</xref>). Furthermore, the extract of <italic>Cistus incanus</italic> showed antiviral activity against HIV and filoviruses by targeting the glycoproteins of the virus envelope resulting in blockage of attachment to receptors (Rebensburg et al., <xref rid="ptr6893-bib-0061" ref-type="ref">2016</xref>). Hence, the chemical investigation and mechanistic study on the antiviral activities of the plants are needed to be carried out.</p><p>Extracts from medicinal plants such as <italic>Dioscorea batatas, Glycyrrhiza radix, Mollugo cerviana, Polygonum multiflorum</italic> Thunb., <italic>Psoralea corylifolia</italic>, <italic>Rheum officinale</italic> Baill., <italic>Salvia miltiorrhiza</italic>, and <italic>Trichosanthes cucumerina</italic> L. were shown active against coronavirus (Alagu Lakshmi, Shafreen, Priya, &#x00026; Shunmugiah, <xref rid="ptr6893-bib-0003" ref-type="ref">2020</xref>; Boukhatem &#x00026; Setzer, <xref rid="ptr6893-bib-0009" ref-type="ref">2020</xref>; Ho, Wu, Chen, Li, &#x00026; Hsiang, <xref rid="ptr6893-bib-0022" ref-type="ref">2007</xref>). In a study, herbal extracts of plants like <italic>Tinospora cordifolia</italic> have already been urged to be used for the patients infected by SARS&#x02010;CoV&#x02010;2 (Li et al., <xref rid="ptr6893-bib-0035" ref-type="ref">2005</xref>). In a study reported by Li et al. (<xref rid="ptr6893-bib-0035" ref-type="ref">2005</xref>), herbal extracts obtained from four different plants <italic>Artemisia annua</italic>, <italic>Lindera aggregata</italic>, <italic>Pyrrosia lingua</italic>, and <italic>Lycoris radiata</italic> have shown remarkable antiviral activity in a cell&#x02010;based stay against the SARS&#x02010;CoV where the alkaloid, lycorine (<bold>1</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2a</xref>) from <italic>L. radiata</italic> has shown effective inhibitory activity to stop the infection caused by SARS&#x02010;CoV on HepG2 and Vero E6 cells culture (Li et al., <xref rid="ptr6893-bib-0035" ref-type="ref">2005</xref>). Similarly, plant&#x02010;based phenolic compounds have shown anti&#x02010;SARS&#x02010;CoV activity in the cell&#x02010;based study (C.&#x02010;W. Lin et al., <xref rid="ptr6893-bib-0037" ref-type="ref">2005</xref>). Another study reported by Lau et al. (<xref rid="ptr6893-bib-0034" ref-type="ref">2008</xref>) has shown that the extract of <italic>Houttuynia cordata</italic> is safe and effective for the treatment of pneumonia caused by SARS&#x02010;CoV (Lau et al., <xref rid="ptr6893-bib-0034" ref-type="ref">2008</xref>).</p><p>In another research, Khaerunnisa, Kurniawan, Awaluddin, Suhartati, and Soetjipto (<xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>) investigated several herbal compounds, which are potent inhibitor of COVID&#x02010;19 M<sub>pro</sub> (main protease) like kaempferol (<bold>2</bold>), quercetin (<bold>3</bold>), luteolin&#x02010;7&#x02010;glucoside (<bold>4</bold>), demethoxycurcumin (<bold>5</bold>), naringenin (<bold>6</bold>), apigenin&#x02010;7&#x02010;glucoside (<bold>7</bold>), oleuropein (<bold>8</bold>), curcumin (<bold>9</bold>) catechin (<bold>10</bold>), epigallocatechin&#x02010;gallate (<bold>11</bold>), zingerol (<bold>12</bold>), gingerol (<bold>13</bold>), and allicin (<bold>14</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2a</xref>) isolated from some flavonoids of medicinal plants (Khaerunnisa et al., <xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>). Utomo, Ikawati, and Meiyanto (<xref rid="ptr6893-bib-0070" ref-type="ref">2020</xref>) shows the likely inhibitory results of <italic>Curcuma</italic> and <italic>Citrus</italic> spp. on the replication and progress of the infection, so hesperidin (<bold>15</bold>) from these species may be used for the development of anti&#x02010;SARS&#x02010;CoV&#x02010;2 drugs as a treatment regime of COVID&#x02010;19 (Utomo et al., <xref rid="ptr6893-bib-0070" ref-type="ref">2020</xref>). Diammonium glycyrrhizinate (<bold>16</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2a</xref>), a herbal compound of the sweet root, has been used to constrain the severe symptoms of COVID&#x02010;19 while this compound is in clinical use for a long time for the treatment of coughs, digestive problems, and liver infection caused by HBV.</p><p>Nevertheless, natural products like amentoflavone (<bold>17</bold>), betulinic acid (<bold>18</bold>), bisbenzylisoquinoline (<bold>19</bold>), blancoxanthone (<bold>20</bold>), chrysanthemumin B (<bold>21</bold>), cryptotanshinone (<bold>22</bold>), escinidin (<bold>23</bold>), hirsutenone (<bold>24</bold>), homoharringtonine (<bold>25</bold>), iguesterin (<bold>26</bold>), jubanine G (<bold>27</bold>), kazinol F (<bold>28</bold>), leptodactylone (<bold>29</bold>), ouabain (<bold>30</bold>), psoralidin (<bold>31</bold>), papyriflavonol A (<bold>32</bold>), schimperinone (<bold>33</bold>), silvestrol (<bold>34</bold>), sinigrin (<bold>35</bold>), tanshinone I (<bold>36</bold>), theaflavin (<bold>37</bold>), tingenone (<bold>38</bold>), tylophorine (<bold>39</bold>), xanthoangelol E (<bold>40</bold>), and 7&#x02010;methoxycryptopleurine (<bold>41</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2b,c</xref>), with antiviral activity, have been reviewed already as potential drugs candidates against SARS&#x02010;CoV&#x02010;2 (Islam et al., <xref rid="ptr6893-bib-0026" ref-type="ref">2020</xref>; Orhan &#x00026; Senol Deniz, <xref rid="ptr6893-bib-0054" ref-type="ref">2020</xref>; Xian et al., <xref rid="ptr6893-bib-0075" ref-type="ref">2020</xref>). In addition to these, different antiviral potent compounds against human viruses have been reviewed (Table 3S, Figure 2Sa,b in <xref rid="ptr6893-supitem-0001" ref-type="supplementary-material">Data S1</xref>). Hence, the screening and identification of potential anti&#x02010;antiviral and anti&#x02010;infectious particles/compounds from medicinal plants/herbs extracts are in global demand.</p></sec><sec id="ptr6893-sec-0003"><label>3</label><title>ANTIVIRAL DRUG CANDIDATES FROM NATURAL PRODUCTS</title><sec id="ptr6893-sec-0004"><label>3.1</label><title>Mechanism</title><p>Polyphenols, flavonoids, proanthocyanidins, saponins, monoterpenoids, triterpenoids, glucosides, sesquiterpenes, and alkaloids isolated from various medicinal plants have diverse antiviral activities of which some are listed in Table <xref rid="ptr6893-tbl-0001" ref-type="table">1</xref>. Antiviral drugs interact with haemagglutinin, which interferes with the entry of the virus. Neuraminidase, an essential glycoprotein required for viral amplification (proliferation and infections), catalyzes the cleavage of &#x003b1;&#x02010;(2,3) or &#x003b1;&#x02010;(2,6) ketosidic linkage between sialic acid and oligosaccharide of glycoproteins such that viruses release from infectious cells (Muchtaridi, Sugijanto, Mohd Gazzali, &#x00026; Wahab, <xref rid="ptr6893-bib-0048" ref-type="ref">2020</xref>). Neuraminidase inhibitors (NAIs) can block the viral enzyme neuraminidase, which prevents the release of viruses from host cells (Liao, Kowal, Cardenas, &#x00026; Beauchemin, <xref rid="ptr6893-bib-0036" ref-type="ref">2017</xref>). There is a strong matching between Query sequence H1N1 neurominidase and SARS&#x02010;CoV&#x02010;2 Orf 3a. Friedeline (<bold>42</bold>), methyl&#x02010;3&#x003b1;,23&#x02010;dihydroxy&#x02010;17,14&#x02010;friedolanstan&#x02010;8,14,24&#x02010;trien&#x02010;26&#x02010;oat (<bold>43</bold>), 24E&#x02010;3a,9,23&#x02010;trihydroxy&#x02010;17,14&#x02010; friedolanostan&#x02010;14,24&#x02010;dien&#x02010;26&#x02010;oate (<bold>44</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>), and catechin (<bold>10</bold>) (Figure 2d) isolated from <italic>Garcinia celebica</italic> L. leaves extract areneuraminidase inhibitors, which bind to active amino acid residues of neuraminidase by hydrogen bonds and van der Waals force and interfere virus release from host cells (Muchtaridi et al., <xref rid="ptr6893-bib-0048" ref-type="ref">2020</xref>).</p><table-wrap id="ptr6893-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Possible antiviral drug candidates from natural products</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Plant sources</th><th align="left" valign="bottom" rowspan="1" colspan="1">Isolated molecules</th><th align="left" valign="bottom" rowspan="1" colspan="1">Active against virus</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Scutellaria baicalensis</italic> Georgi</td><td align="left" valign="top" rowspan="1" colspan="1">Isoscutellarein (<bold>76</bold>)</td><td align="left" valign="top" rowspan="1" colspan="1">Influenza virus</td><td align="left" valign="top" rowspan="1" colspan="1">(Nagai, Miyaichi, Tomimori, Suzuki, &#x00026; Yamada, <xref rid="ptr6893-bib-0050" ref-type="ref">1992</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Kaempferia parviflora</italic> Wall. ex Baker</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>5,7&#x02010;Dimethoxyflavone (<bold>77</bold>),</p>
<p>Tetramethyllueteonin (<bold>78</bold>),</p>
<p>Tri methyl apigenin (<bold>79</bold>),</p>
<p>5&#x02010;Hydroxy&#x02010;7&#x02010;methoxyflavone (<bold>80</bold>),</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Avian influenza virus (H5N1)</td><td align="left" valign="top" rowspan="1" colspan="1">(Sornpet, Potha, Tragoolpua, &#x00026; Pringproa, <xref rid="ptr6893-bib-0066" ref-type="ref">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Curcuma longa</italic> L.</td><td align="left" valign="top" rowspan="1" colspan="1">Curcumin(diferuloylmethane) (<bold>9</bold>)</td><td align="left" valign="top" rowspan="1" colspan="1">H5N1</td><td align="left" valign="top" rowspan="1" colspan="1">(Sornpet et al., <xref rid="ptr6893-bib-0066" ref-type="ref">2017</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Ginkgo biloba</italic> L., <italic>Cephalotaxus harringtonia</italic> K.</td><td align="left" valign="top" rowspan="1" colspan="1">Ginkgetin (<bold>81</bold>)</td><td align="left" valign="top" rowspan="1" colspan="1">Influenza virus</td><td align="left" valign="top" rowspan="1" colspan="1">(Miki et al., <xref rid="ptr6893-bib-0045" ref-type="ref">2007</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Houttuynia cordata</italic> Thunb.</td><td align="left" valign="top" rowspan="1" colspan="1">Quercetin 3&#x02010;rhamnoside (<bold>82</bold>)</td><td align="left" valign="top" rowspan="1" colspan="1">Influenza virus</td><td align="left" valign="top" rowspan="1" colspan="1">(Choi, Song, Park, &#x00026; Kwon, <xref rid="ptr6893-bib-0012" ref-type="ref">2009</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Tripterygium regelii</italic> Sprague &#x00026;Takeda</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Celastrol (<bold>83</bold>), Pristimerin (<bold>84</bold>),</p>
<p>Tingenone (<bold>85</bold>), Iguesterin (<bold>26</bold>)</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">SARS&#x02010;CoV</td><td align="left" valign="top" rowspan="1" colspan="1">(Ryu et al., <xref rid="ptr6893-bib-0065" ref-type="ref">2010</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Ecklonia cava</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>Dieckol (<bold>86</bold>), Eckol (<bold>87</bold>),</p>
<p>Triphloretol A (<bold>88</bold>), Dioxinodehydroeckol (<bold>89</bold>),</p>
<p>2&#x02010;Phloroeckol (<bold>90</bold>), 7&#x02010;Phloroeckol (<bold>91</bold>),</p>
<p>Phlorofucofuroeckol A (<bold>92</bold>), Fucodiphloroethol G (<bold>93</bold>)</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">SARS&#x02010;CoV</td><td align="left" valign="top" rowspan="1" colspan="1">(Park et al., <xref rid="ptr6893-bib-0055" ref-type="ref">2013</xref>)</td></tr></tbody></table><table-wrap-foot id="ptr6893-ntgp-0001"><fn id="ptr6893-note-0001"><p>
<italic>Note:</italic> Catechin (<bold>10</bold>): immunostimulatory and antimitotic inhibitors; Coumarin (<bold>9</bold>): Protease Inhibitors For chemical structures of compounds refer to Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2f,g</xref>.</p></fn></table-wrap-foot></table-wrap><p>A polyphenol, pentagalloylglucose (PGG) (<bold>45</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>) demonstrated anti&#x02010;influenza virus activity by reducing virus release, site of virus assembly, and budding (microvillus) and inhibiting hemagglutination induced by the virus (G. Liu et al., <xref rid="ptr6893-bib-0039" ref-type="ref">2011</xref>). Amplification of the HCV was inhibited by non&#x02010;nucleoside inhibitors (benzimidazole scaffold) through inhibition of RdRP, and its mechanism of action was studied (Tomei et al., <xref rid="ptr6893-bib-0069" ref-type="ref">2003</xref>).</p><p>Glycyrrhizic acid (GL) (<bold>46</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>) inhibited Epstein&#x02013;Barr virus (EBV) replication with an IC<sub>50</sub> value of 0.004&#x02009;mM by inhibiting viral DNA polymerase GL showed antiviral activity against SARS&#x02010;CoVs in Vero cells with a SI of 67 by reducing replication and inhibiting penetration and adsorption of the virus (Cinatl et al., <xref rid="ptr6893-bib-0013" ref-type="ref">2003</xref>). 2&#x02010;Acetamido&#x02010;&#x003b2;&#x02010;D&#x02010;glucopyansylamine (<bold>47</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>) suppressed the expression of viral antigen (&#x0003e;99%) with an inhibition of 40&#x02009;&#x003bc;M toward SARS&#x02010;CoV replication (Hoever et al., <xref rid="ptr6893-bib-0023" ref-type="ref">2005</xref>). Pyridine&#x02010;N&#x02010;oxide derivatives were found active against HIV&#x02010;1, HIV&#x02010;2, HCMV, and also inhibited SARS&#x02010;CoVs by targeting the transcription level of the virus cycle (Balzarini et al., <xref rid="ptr6893-bib-0005" ref-type="ref">2006</xref>).</p><p>Acacetin (<bold>48</bold>), auraptene (<bold>49</bold>), cardamonin (<bold>50</bold>), daidzein (<bold>51</bold>), epicatechin (<bold>52</bold>), glabridin (<bold>53</bold>), herbacetin (<bold>54</bold>), isoxanthohumol (<bold>55</bold>), and taxifolin hydrate (<bold>56</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>) showed antiviral activity by suppressing SARS&#x02010;CoV 3C protease (3Cpro) (Jo, Kim, Shin, &#x00026; Kim, <xref rid="ptr6893-bib-0029" ref-type="ref">2020</xref>) while herbacetin (<bold>54</bold>), isobavachalcone (<bold>57</bold>), quercetin 3&#x02010;<italic>&#x003b2;</italic>&#x02010;D&#x02010;glucoside (<bold>58</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2d</xref>), and helichrysetin (<bold>59</bold>) inhibited MERS&#x02010;CoV 3Cpro activity (Jo, Kim, Kim, Shin, &#x00026; Kim, <xref rid="ptr6893-bib-0028" ref-type="ref">2019</xref>).</p><p>Different compounds possess antiviral activity by effecting or targeting different stages of their replication life cycle, that is, adsorption, penetration, uncoating, transcription, replication, assembly, and release (De Clercq, <xref rid="ptr6893-bib-0015" ref-type="ref">1982</xref>).</p><p>Antiviral drugs undergo action by (a) acting as blocking agent during adsorption and penetration of virus on receptors; (b) inactivation of virus particles; (c) altering properties of virus membrane; (d) inhibition of viral enzymes (DNA polymerase, RNA polymerase, deoxypyrimidine nucleoside kinase, and thymidine kinase, viral neuraminidase, mRNA guanylyltransferase, and mRNA Methyltransferase); (e) inhibiting reverse transcriptase; (f) inhibiting translational process; (g) decrease in expression level; (h) inhibiting viral assembly; (i) reduced endocytic activity (Calland, Dubuisson, Rouill&#x000e9;, &#x00026; S&#x000e9;ron, <xref rid="ptr6893-bib-0010" ref-type="ref">2012</xref>; De Clercq, <xref rid="ptr6893-bib-0015" ref-type="ref">1982</xref>; Ichikawa &#x00026; Matsuda, <xref rid="ptr6893-bib-0025" ref-type="ref">2007</xref>).</p></sec><sec id="ptr6893-sec-0005"><label>3.2</label><title>Inhibition of viral protease</title><p>Protease inhibitors alter or deactivate the configuration of protease involved in the proteolytic activity (events) associated with diseases like AIDS, cancer, thrombosis, hepatitis, and cirrhosis (Mishra, Reddy &#x00026; Prasad, 2020). Fisetin (<bold>60</bold>) and rutin (<bold>61</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>) act as a 3C protease (3Cpro) inhibitors against enterovirus A71 with IC<sub>50</sub> of 85 and 110&#x02009;&#x003bc;M, respectively (Y.&#x02010;J. Lin et al., <xref rid="ptr6893-bib-0038" ref-type="ref">2012</xref>). Some drugs from the primary investigations that are used for COVID&#x02010;19 are protease inhibitor lopinavir/ritonavir, nucleoside analogs, neuraminidase inhibitors, remdesivir, umifenovir (arbidol), tenofovir disoproxil (TDF), lamivudine (3TC) and hydroxychloroquine, which blocks virus entry and endocytosis (Lu, <xref rid="ptr6893-bib-0042" ref-type="ref">2020</xref>) (Figure <xref rid="ptr6893-fig-0001" ref-type="fig">1</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6893-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Multliplication stages of virus in a living cell and major antiviral drugs with their mode of action <ext-link ext-link-type="uri" xlink:href="http://biorender.com">http://biorender.com</ext-link> [Colour figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>]</p></caption><graphic id="nlm-graphic-1" xlink:href="PTR-9999-na-g001"/></fig><p>A protease inhibitor, lopinavir/ritonavir, which is commonly used to treat HIV/AIDS patients, could be used for the treatment of COVID&#x02010;19&#x02010;infected patients. Coumarin (<bold>62</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>) has a broad spectrum of antiviral activity against hepatitis virus, dengue virus, chikungunya virus, and influenza virus by inhibiting viral proteins required for their entry, replication, and infection, and/or by regulation of cellular and antioxidative pathways (Mishra, Pandey &#x00026; Manvati, 2020). Caffeic acid (<bold>63</bold>) and 5&#x02010;caffeoylquinic acid (<bold>64</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>) from <italic>Achyrocline satureioides</italic> inhibit the protein HIV integrase essential for viral DNA integration into host chromatin (Khaerunnisa et al., <xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>; Robinson, Reinecke, Abdel&#x02010;Malek, Jia, &#x00026; Chow, <xref rid="ptr6893-bib-0062" ref-type="ref">1996</xref>).</p><fig fig-type="FIGURE" xml:lang="en" id="ptr6893-fig-0002" orientation="portrait" position="float"><label>FIGURE 2</label><caption><p>(a) Natural compounds isolated from medicinal plants for antiviral activity: Lycorine (1), Kaempferol (2), Quercetin (3), Luteolin&#x02010;7&#x02010;glucoside (4), Demethoxycurcumin (5), Naringenin (6), Apigenin&#x02010;7&#x02010;glucoside (7), Oleuropein (8), Curcumin (9), Catechin (10), Epigallocatechin&#x02010;gallate (11), Zingerol (12), Gingerol (13), Allicin (14), Hesperidin (15),Diammonium glycyrrhizinate (16). (b) Natural compounds isolated from medicinal plants for antiviral activity: Amentoflavone (17), Betulinic acid (18), Bisbenzylisoquinoline (19), Blancoxanthone (20), Chrysanthemumin B (21), Cryptotanshinone (22), Escinidin (23), Hirsutenone (24), Homoharringtonine (25), Iguesterin (26), Jubanine G (27), Kazinol F (28), Leptodactylone (29), Ouabain (30), Psoralidin (31), Papyriflavonol A (32). (c) Natural compounds isolated from medicinal plants for antiviral activity: Schimperinone (33), Silvestrol (34), Sinigrin (35), Tanshinone I (36), Theaflavin (37), Tingenone (38), Tylophorine (39), Xanthoangelol E (40), 7&#x02010;Methoxycryptopleurine (41). (d) Natural compounds isolated from medicinal plants for antiviral activity: Friedeline (42), Methyl&#x02010;3&#x003b1;,23&#x02010;dihydroxy&#x02010;17,14&#x02010;friedolanstan&#x02010;8,14,24&#x02010;trien&#x02010;26&#x02010;oat (43), 24E&#x02010;3a,9,23&#x02010;trihydroxy&#x02010;17,14&#x02010; friedolanostan&#x02010;14,24&#x02010;dien&#x02010;26&#x02010;oate (44), Pentagalloylglucose (PGG) (45), Glycyrrhizic acid (46), 2&#x02010;Acetamido&#x02010;&#x003b2;&#x02010;D&#x02010;glucopyansylamine (47), Acacetin (48), Auraptene (49), Cardamonin (50), Daidzein (51), Epicatechin (52), Glabridin (53), Herbacetin (54), Isoxanthohumol (55), Taxifolin hydrate (56), Isobavachalcone (57), Quercetin 3&#x02010;&#x003b2;&#x02010;D&#x02010;glucoside (58). (e) Natural compounds isolated from medicinal plants for antiviral activity: Helichrysetin (59), Fisetin (60), Rutin (61), Coumarin (62), Caffeic acid (63), 5&#x02010;Caffeoylquinic acid (64), Calanolide A (65), Baicalin (66), Emodin (67), Pectolinarin (68), Cannabinoids (69), Rhoifolin (70), Diosmin (71), Apiin (72), Diacetylcurcumin (73). (f) Natural compounds isolated from medicinal plants for antiviral activity: (E)&#x02010;1&#x02010;(2&#x02010;Hydroxy&#x02010;4&#x02010;methoxyphenyl)&#x02010;3&#x02010;[3&#x02010;[(E)&#x02010;3&#x02010;(2&#x02010;hydroxy&#x02010;4&#x02010;methoxyphenyl)&#x02010;3&#x02010;oxoprop&#x02010;1&#x02010;enyl]phenyl]prop&#x02010;2&#x02010;en&#x02010;1&#x02010;one (74), beta,beta&#x02032;&#x02010;(4&#x02010;Methoxy&#x02010;1,3&#x02010;phenylene)bis(2&#x02032;&#x02010;hydroxy&#x02010;4&#x02032;,6&#x02032;&#x02010;dimethoxyacrylophenone (75), Isoscutellarein (76), 5,7&#x02010;Dimethoxyflavone (77), Tetramethyllueteonin (78), Tri methyl apigenin (79),5&#x02010;Hydroxy&#x02010;7&#x02010;methoxyflavone (80), Ginkgetin (81), Quercetin 3&#x02010;rhamnoside (82), Celastrol (83), Pristimerin (84), Tingenone (85). (g) Natural compounds isolated from medicinal plants for antiviral activity: Dieckol (86), Eckol (87), Triphloretol A (88), Dioxinodehydroeckol (89), 2&#x02010;Phloroeckol (90), 7&#x02010;Phloroeckol (91), Phlorofucofuroeckol A (92), Fucodiphloroethol G (93)</p></caption><graphic id="nlm-graphic-3" xlink:href="PTR-9999-na-g002"/></fig></sec><sec id="ptr6893-sec-0006"><label>3.3</label><title>Inhibition of viral replication steps</title><p>Coronavirus genome encodes a protein called RNA&#x02010;dependent RNA polymerase (RdRP), which allows the viral genome to be transcribed into new RNA copies using the host cell's machinery. Thus, inhibition of RdRP could be a potential target for the control of viral infection. Epigallocatechin&#x02010;3&#x02010;gallate (<bold>11</bold>), calanolide A (<bold>65</bold>), and baicalin (<bold>66</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>) inhibit virus replication (Kitazato, Wang, &#x00026; Kobayashi, <xref rid="ptr6893-bib-0033" ref-type="ref">2007</xref>). Many other nucleoside analogs, including DNA synthesis inhibitors such as tenofovir, disoproxil, lamivudine, and similar other antiviral agents, have the potential to inhibit the SARS&#x02010;CoV&#x02010;2 multiplication. They are being evaluated through molecular docking studies and testing in laboratory culture infected cells (Khaerunnisa et al., <xref rid="ptr6893-bib-0031" ref-type="ref">2020</xref>).</p></sec><sec id="ptr6893-sec-0007"><label>3.4</label><title>Inhibition of viral spike protein and receptor</title><p>Spike glycoprotein of SARS&#x02010;CoV&#x02010;2 contains a receptor&#x02010;binding domain (RBD) that recognizes the target receptor. The receptor angiotensin&#x02010;converting enzyme&#x02010;2 (ACE&#x02010;2) is a preferable receptor for SARS&#x02010;CoV&#x02010;2 (Peng et al., <xref rid="ptr6893-bib-0056" ref-type="ref">2020</xref>). Furin blocks a spike protein of mouse hepatitis coronavirus required for attachment and fusion during infection (Bosch, van der Zee, de Haan, &#x00026; Rottier, <xref rid="ptr6893-bib-0008" ref-type="ref">2003</xref>; de Haan, Stadler, Godeke, Bosch, &#x00026; Rottier, <xref rid="ptr6893-bib-0018" ref-type="ref">2004</xref>). Emodin (<bold>67</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>) inhibits the spike protein and ACE&#x02010;2 interaction preventing coronavirus entry (Ho et al., <xref rid="ptr6893-bib-0022" ref-type="ref">2007</xref>). Secondary metabolites like hesperidin (<bold>15</bold>), pectolinarin (<bold>68</bold>), cannabinoids (<bold>69</bold>), rhoifolin (<bold>70</bold>), diosmin (<bold>71</bold>), apiin (<bold>72</bold>), diacetylcurcumin (<bold>73</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2e</xref>), epigallocatechin gallate (<bold>11</bold>), (E)&#x02010;1&#x02010;(2&#x02010;Hydroxy&#x02010;4&#x02010;methoxyphenyl)&#x02010;3&#x02010;[3&#x02010;[(E)&#x02010;3&#x02010;(2&#x02010;hydroxy&#x02010;4&#x02010;methoxyphenyl)&#x02010;3&#x02010;oxoprop&#x02010;1&#x02010;enyl]phenyl]prop&#x02010;2&#x02010;en&#x02010;1&#x02010;one (<bold>74</bold>), and beta,beta&#x02032;&#x02010;(4&#x02010;Methoxy&#x02010;1,3&#x02010;phenylene)bis(2&#x02032;&#x02010;hydroxy&#x02010;4&#x02032;,6&#x02032;&#x02010;dimethoxyacrylophenone (<bold>75</bold>) (Figure <xref rid="ptr6893-fig-0002" ref-type="fig">2f</xref>) from medicinal plants are bioactive against SARS&#x02010;CoV&#x02010;2 main protease and spike glycoprotein so, it is necessary to screen all the available antiviral drugs against COVID&#x02010;19 for faster development of therapeutic option to control the pandemic (Adem, Eyupoglu, Sarfraz, Rasul, &#x00026; Ali, <xref rid="ptr6893-bib-0002" ref-type="ref">2020</xref>; Peng et al., <xref rid="ptr6893-bib-0056" ref-type="ref">2020</xref>).</p></sec></sec><sec id="ptr6893-sec-0008"><label>4</label><title>SCREENING OF MEDICINAL PLANTS</title><p>There are various methods available for in vivo and in vitro screening of extracts of medicinal plants. Notably, this review focused on a little known method in the area of medicinal chemistry, which is mostly known as emulsion&#x02010;based in vitro compartmentalization (IVC) technique (Gianella, Snapp, &#x00026; Levy, <xref rid="ptr6893-bib-0020" ref-type="ref">2016</xref>). For this purpose, a &#x0201c;water&#x02010;in&#x02010;oil&#x02010;in&#x02010;water&#x0201d; emulsion is used in the compartmentalization of droplets for ultrahigh throughput screening (uHTS). Usually, IVC uses aqueous droplets that contain DNA and machinery for protein production within water&#x02010;in&#x02010;oil emulsions (Rothe, Surjadi, &#x00026; Power, <xref rid="ptr6893-bib-0064" ref-type="ref">2006</xref>). In the modified protocol, template viral DNA tagged with a Green fluorescent protein (GFP) could be compartmentalized along with RdRP and plant extracts (or compounds). If RdRP is inhibited due to plant extracts and/or pure compounds, fluorescence switches off, and target droplets could be sorted using fluorescence&#x02010;activated cell sorting (FACS) (Bernath et al., <xref rid="ptr6893-bib-0007" ref-type="ref">2004</xref>). Reprogramming of similar techniques could be explored to study the inhibition of viral protease. Different cell cultures assays, chips&#x02010;based methods, animal models, and enzyme inhibition assays have been carried to find potent antiviral compounds from natural sources (Anani et al., <xref rid="ptr6893-bib-0004" ref-type="ref">2000</xref>; Lloyd, Russell, Blanes, Doble, &#x00026; Roux, <xref rid="ptr6893-bib-0041" ref-type="ref">2013</xref>; Mukhtar et al., <xref rid="ptr6893-bib-0049" ref-type="ref">2008</xref>; Ogbole, Segun, &#x00026; Adeniji, <xref rid="ptr6893-bib-0053" ref-type="ref">2017</xref>). Additionally, for a couple of decades, the analysis, process, and development of herbal ingredients have dramatically increased with innovation in laboratory techniques and instrumentation (Fitzgerald, Heinrich, &#x00026; Booker, <xref rid="ptr6893-bib-0019" ref-type="ref">2020</xref>).</p></sec><sec id="ptr6893-sec-0009"><label>5</label><title>FUTURE PERSPECTIVES</title><p>Several synthetic drugs are showing inefficiency for the treatment of patients suffering from SARS&#x02010;CoV&#x02010;2, so herbal medicines have become a promising option to tackle the ongoing pandemic caused by COVID&#x02010;19. Some of the Chinese plant extracts have already been examined for the treatment of COVID&#x02010;19 patients in the clinical setting and have shown effective outcomes for the palliation of symptoms (Luo et al., <xref rid="ptr6893-bib-0043" ref-type="ref">2020</xref>). Prescription of typical herbs at the time of viral infections is in practice in India for the optimum immunity and better physiological status of the patients (Kim et al., <xref rid="ptr6893-bib-0032" ref-type="ref">2008</xref>). Use of diammonium glycyrrhizinate with vitamin C for the treatment of COVID&#x02010;19 associated infections has been approved via a randomized, controlled, and open clinical trial in Zhongnan Hospital of Wuhan University, Hubei, China where safety and efficiency of diammonium glycyrrhizinate with vitamin C for the treatment of COVID&#x02010;19 infected patients was investigated but clinical use has not commenced yet. Except earmarking on viral protease, replication, spike protein, and receptor, its protein kinase C and helicase have also been established as potential targets to inhibit SARS&#x02010;CoV (Hoever et al., <xref rid="ptr6893-bib-0023" ref-type="ref">2005</xref>; Jang et al., <xref rid="ptr6893-bib-0027" ref-type="ref">2020</xref>). Glycyrrhizin has been revealed as a potential inhibitor of SARS CoV protein kinase C and similarly, myricetin and scutellarein as aptitude inhibitor of viral helicase (Xian et al., <xref rid="ptr6893-bib-0075" ref-type="ref">2020</xref>). A large number of Chinese herbal&#x02010;based medicines were used in China for the treatment of patients infected by COVID&#x02010;19. The National Health Commission (NHC) of China has recommended a couple of plants originated medicines for the treatment of SARS&#x02010;CoV&#x02010;2 patients. China used a similar treatment strategy even in 2003 when the SARS&#x02010;CoV outbreak was reported. Chinese experts claim that herbal drugs such as <italic>Radix isatidis</italic> granula, and Huoxiang Zhengqi soft capsules have an excellent function to improve problems like weakness, coughs, anxiety, and digestive disorder. Plant&#x02010;based medicines were also deployed in the earlier two outbreaks of coronavirus, which were SARS&#x02010;CoV of 2003 and MERS&#x02010;CoV of 2012 (&#x0201c;Redeploying Plant Defences,&#x0201d; <xref rid="ptr6893-bib-0051" ref-type="ref">2020</xref>).</p><p>Herbal&#x02010;based antiviral medicines have shown promising inhibitory effects, which range from anti&#x02010;influenza to anti&#x02010;dengue properties (Table <xref rid="ptr6893-tbl-0001" ref-type="table">1</xref>). In the context of the global burden of COVID&#x02010;19, where an absolute medicine is waiting for patients, promptly available plant&#x02010;based medicines with studied safety and efficacy can be on the frontline to tackle the ongoing calamity caused by COVID&#x02010;19. The problems encountered while using bioactive secondary metabolites like their solubility, stability, and bioavailability need to be addressed to use these metabolites as medicine (Coimbra et al., <xref rid="ptr6893-bib-0014" ref-type="ref">2011</xref>). Moreover, the application of artificial intelligence tools like molecular docking studies, toxicity analysis, and pharmacological studies would further add significant information regarding potency of the aforementioned secondary metabolites. However, the mutation occurring in targets should be taken into account. Extensive studies and investments are demanding for new drug development strategies using herbal extracts to save sapiens lives on our planet from pandemics like COVID&#x02010;19, today, and tomorrow.</p></sec><sec id="ptr6893-sec-0010"><label>6</label><title>CONCLUSIONS</title><p>There are barely any countries that are left untouched by the COVID&#x02010;19 pandemic. It is one of the greatest public health threats to date that needs to be controlled as soon as possible. Still today, there are no vaccines or drugs that have been clinically proven against COVID&#x02010;19. Many secondary metabolites with antiviral properties have been isolated from medicinal plants. Various researches have been carried out throughout the world to develop antiviral drugs effective against SARS&#x02010;CoV&#x02010;2 responsible for COVID&#x02010;19. The best way of preventing COVID&#x02010;19 infections could be finding the compounds responsible for altering or disturbing any steps of the virus replication cycle. Natural products capable of inhibiting or altering the configuration of structural proteins (spike glycoprotein), non&#x02010;structural proteins (3&#x02010;chymotrypsin&#x02010;like protease, papain&#x02010;like protease, helicase, and RdRP) and accessory proteins coded by SARS&#x02010;CoV&#x02010;2 genome are needed to be explored. Usually, natural products could be a safe, secure, and dependable source to find drugs responsible for controlling the current pandemic. Protease and RNA polymerase inhibitors known to be active against SARS and MERS are also required to be explored. Different compounds (flavonoids, polyphenols, alkaloids, proanthocyanidins, and terpenoids), which are already known to have antiviral activities, need to be rapidly screened for the treatment of SARS&#x02010;CoV&#x02010;2 infected patients. In the context of not having proven medication of COVID19, patients depend on supportive care and symptomatic therapy. Hence, many herbal extract and natural products may help to treat the symptoms associated with SARS&#x02010;CoV&#x02010;2 infection.</p></sec><sec sec-type="COI-statement" id="ptr6893-sec-0012"><title>CONFLICT OF INTEREST</title><p>The authors declare that there is no conflict of interest regarding the publication of this paper.</p></sec><sec id="ptr6893-sec-0013"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Bikash Adhikari, Ganesh Lamichhane, Bibek Raj Bhattarai, Karan Khadayat, Achyut Adhikari, and Niranjan Parajuli:</bold> Reviewed the literature of natural products. <bold>Achyut Adhikari and Bibek Raj Bhattarai:</bold> Drawn chemical structures. <bold>Binod Rayamajhee, Bishnu P. Marasini, and Santosh Khanal:</bold> Reviewed the literature on coronavirus and COVID&#x02010;19.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="ptr6893-supitem-0001"><caption><p>
<bold>Data S1.</bold> Supporting information.</p></caption><media xlink:href="PTR-9999-na-s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="ptr6893-sec-0011"><title>ACKNOWLEDGEMENTS</title><p>We acknowledge Mr. Sagar Aryal for providing the figures showing antiviral drugs and site of action, and genomic organization of SARS&#x02010;CoV&#x02010;2 through <ext-link ext-link-type="uri" xlink:href="http://biorender.com">biorender.com</ext-link>.</p></ack><ref-list id="ptr6893-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="ptr6893-bib-0001"><mixed-citation publication-type="journal" id="ptr6893-cit-0001">
<string-name>
<surname>Abad</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Guerra</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Bermejo</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Irurzun</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Carrasco</surname>, <given-names>L.</given-names>
</string-name> (<year>2000</year>). <article-title>Search for antiviral activity in higher plant extracts</article-title>. <source xml:lang="en">Phytotherapy Research</source>, <volume>14</volume>(<issue>8</issue>), <fpage>604</fpage>&#x02013;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1002/1099-1573(200012)14:8&#x0003c;604::AID-PTR678&#x0003e;3.0.CO;2-L</pub-id>
<pub-id pub-id-type="pmid">11113996</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0002"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0002">
<string-name>
<surname>Adem</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Eyupoglu</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Sarfraz</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Rasul</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ali</surname>, <given-names>M.</given-names>
</string-name> (<year>2020</year>). <italic>Identification of potent COVID&#x02010;19 main protease (M</italic>
<sup><italic>pro</italic></sup>
<italic>) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA</italic> Retrieved from <pub-id pub-id-type="doi">10.20944/preprints202003.0333.v1</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0003"><mixed-citation publication-type="journal" id="ptr6893-cit-0003">
<string-name>
<surname>Alagu Lakshmi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shafreen</surname>, <given-names>R. M. B.</given-names>
</string-name>, <string-name>
<surname>Priya</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Shunmugiah</surname>, <given-names>K. P.</given-names>
</string-name> (<year>2020</year>). <article-title>Ethnomedicines of Indian origin for combating COVID&#x02010;19 infection by hampering the viral replication: Using structure&#x02010;based drug discovery approach</article-title>. <source xml:lang="en">Journal of Biomolecular Structure &#x00026; Dynamics</source>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2020.1778537</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0004"><mixed-citation publication-type="journal" id="ptr6893-cit-0004">
<string-name>
<surname>Anani</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Hudson</surname>, <given-names>J. B.</given-names>
</string-name>, <string-name>
<surname>de Souza</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Akpagana</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Tower</surname>, <given-names>G. H. N.</given-names>
</string-name>, <string-name>
<surname>Arnason</surname>, <given-names>J. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gbeassor</surname>, <given-names>M.</given-names>
</string-name> (<year>2000</year>). <article-title>Investigation of medicinal plants of Togo for antiviral and antimicrobial activities</article-title>. <source xml:lang="en">Pharmaceutical Biology</source>, <volume>38</volume>(<issue>1</issue>), <fpage>40</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1076/1388-0209(200001)3811-BFT040</pub-id>
<pub-id pub-id-type="pmid">21214438</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0005"><mixed-citation publication-type="journal" id="ptr6893-cit-0005">
<string-name>
<surname>Balzarini</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Keyaerts</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Vijgen</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Vandermeer</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>De Clercq</surname>, <given-names>E.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Van Ranst</surname>, <given-names>M.</given-names>
</string-name> (<year>2006</year>). <article-title>Pyridine N&#x02010;oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture</article-title>. <source xml:lang="en">Journal of Antimicrobial Chemotherapy</source>, <volume>57</volume>(<issue>3</issue>), <fpage>472</fpage>&#x02013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dki481</pub-id>
<pub-id pub-id-type="pmid">16387746</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0006"><mixed-citation publication-type="journal" id="ptr6893-cit-0006">
<string-name>
<surname>Bauer</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Br&#x000f6;nstrup</surname>, <given-names>M.</given-names>
</string-name> (<year>2014</year>). <article-title>Industrial natural product chemistry for drug discovery and development</article-title>. <source xml:lang="en">Natural Product Reports</source>, <volume>31</volume>(<issue>1</issue>), <fpage>35</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1039/C3NP70058E</pub-id>
<pub-id pub-id-type="pmid">24142193</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0007"><mixed-citation publication-type="journal" id="ptr6893-cit-0007">
<string-name>
<surname>Bernath</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Hai</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mastrobattista</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Griffiths</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Magdassi</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Tawfik</surname>, <given-names>D. S.</given-names>
</string-name> (<year>2004</year>). <article-title>In vitro compartmentalization by double emulsions: Sorting and gene enrichment by fluorescence activated cell sorting</article-title>. <source xml:lang="en">Analytical Biochemistry</source>, <volume>325</volume>(<issue>1</issue>), <fpage>151</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.ab.2003.10.005</pub-id>
<pub-id pub-id-type="pmid">14715296</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0008"><mixed-citation publication-type="journal" id="ptr6893-cit-0008">
<string-name>
<surname>Bosch</surname>, <given-names>B. J.</given-names>
</string-name>, <string-name>
<surname>van der Zee</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>de Haan</surname>, <given-names>C. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rottier</surname>, <given-names>P. J.</given-names>
</string-name> (<year>2003</year>). <article-title>The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex</article-title>. <source xml:lang="en">Journal of Virology</source>, <volume>77</volume>(<issue>16</issue>), <fpage>8801</fpage>&#x02013;<lpage>8811</lpage>.<pub-id pub-id-type="pmid">12885899</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0009"><mixed-citation publication-type="journal" id="ptr6893-cit-0009">
<string-name>
<surname>Boukhatem</surname>, <given-names>M. N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Setzer</surname>, <given-names>W. N.</given-names>
</string-name> (<year>2020</year>). <article-title>Aromatic herbs, medicinal plant&#x02010;derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: Future perspectives</article-title>. <source xml:lang="en">Plants (Basel, Switzerland)</source>, <volume>9</volume>(<issue>6</issue>), 800. <pub-id pub-id-type="doi">10.3390/plants9060800</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0010"><mixed-citation publication-type="journal" id="ptr6893-cit-0010">
<string-name>
<surname>Calland</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Dubuisson</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Rouill&#x000e9;</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>S&#x000e9;ron</surname>, <given-names>K.</given-names>
</string-name> (<year>2012</year>). <article-title>Hepatitis C virus and natural compounds: A new antiviral approach?</article-title>
<source xml:lang="en">Viruses</source>, <volume>4</volume>(<issue>10</issue>), <fpage>2197</fpage>&#x02013;<lpage>2217</lpage>. <pub-id pub-id-type="doi">10.3390/v4102197</pub-id>
<pub-id pub-id-type="pmid">23202460</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0011"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0011">
<collab collab-type="authors">CDC</collab>
. (<year>2020</year>, April 17). <italic>Coronavirus disease 2019 (COVID&#x02010;19) &#x02013; Symptoms</italic> Centers for Disease Control and Prevention. Retrieved from <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html">https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html</ext-link>
</mixed-citation></ref><ref id="ptr6893-bib-0012"><mixed-citation publication-type="journal" id="ptr6893-cit-0012">
<string-name>
<surname>Choi</surname>, <given-names>H. J.</given-names>
</string-name>, <string-name>
<surname>Song</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>K. S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kwon</surname>, <given-names>D. H.</given-names>
</string-name> (<year>2009</year>). <article-title>Inhibitory effects of quercetin 3&#x02010;rhamnoside on influenza A virus replication</article-title>. <source xml:lang="en">European Journal of Pharmaceutical Sciences</source>, <volume>37</volume>(<issue>3&#x02013;4</issue>), <fpage>329</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2009.03.002</pub-id>
<pub-id pub-id-type="pmid">19491023</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0013"><mixed-citation publication-type="journal" id="ptr6893-cit-0013">
<string-name>
<surname>Cinatl</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Morgenstern</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Chandra</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Rabenau</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Doerr</surname>, <given-names>H.</given-names>
</string-name> (<year>2003</year>). <article-title>Glycyrrhizin, an active component of liquorice roots, and replication of SARS&#x02010;associated coronavirus</article-title>. <source xml:lang="en">The Lancet</source>, <volume>361</volume>(<issue>9374</issue>), <fpage>2045</fpage>&#x02013;<lpage>2046</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)13615-X</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0014"><mixed-citation publication-type="journal" id="ptr6893-cit-0014">
<string-name>
<surname>Coimbra</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Isacchi</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>van Bloois</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Torano</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Ket</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>X.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Schiffelers</surname>, <given-names>R. M.</given-names>
</string-name> (<year>2011</year>). <article-title>Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes</article-title>. <source xml:lang="en">International Journal of Pharmaceutics</source>, <volume>416</volume>(<issue>2</issue>), <fpage>433</fpage>&#x02013;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpharm.2011.01.056</pub-id>
<pub-id pub-id-type="pmid">21291975</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0015"><mixed-citation publication-type="journal" id="ptr6893-cit-0015">
<string-name>
<surname>De Clercq</surname>, <given-names>E.</given-names>
</string-name> (<year>1982</year>). <article-title>Specific targets for antiviral drugs</article-title>. <source xml:lang="en">Biochemical Journal</source>, <volume>205</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1042/bj2050001</pub-id>
<pub-id pub-id-type="pmid">6181775</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0016"><mixed-citation publication-type="journal" id="ptr6893-cit-0016">
<string-name>
<surname>De Clercq</surname>, <given-names>E.</given-names>
</string-name> (<year>2004</year>). <article-title>Antivirals and antiviral strategies</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>, <volume>2</volume>, <fpage>704</fpage>&#x02013;<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro975</pub-id>
<pub-id pub-id-type="pmid">15372081</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0017"><mixed-citation publication-type="journal" id="ptr6893-cit-0017">
<string-name>
<surname>De Clercq</surname>, <given-names>E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Li</surname>, <given-names>G.</given-names>
</string-name> (<year>2016</year>). <article-title>Approved antiviral drugs over the past 50&#x02009;years</article-title>, <volume>29</volume>(<issue>3</issue>), <fpage>695</fpage>&#x02013;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00102-15</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0018"><mixed-citation publication-type="journal" id="ptr6893-cit-0018">
<string-name>
<surname>de Haan</surname>, <given-names>C. A. M.</given-names>
</string-name>, <string-name>
<surname>Stadler</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Godeke</surname>, <given-names>G.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Bosch</surname>, <given-names>B. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rottier</surname>, <given-names>P. J. M.</given-names>
</string-name> (<year>2004</year>). <article-title>Cleavage inhibition of the murine coronavirus spike protein by a furin&#x02010;like enzyme affects cell&#x02010;cell but not virus&#x02010;cell fusion</article-title>. <source xml:lang="en">Journal of Virology</source>, <volume>78</volume>(<issue>11</issue>), <fpage>6048</fpage>&#x02013;<lpage>6054</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.11.6048-6054.2004</pub-id>
<pub-id pub-id-type="pmid">15141003</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0019"><mixed-citation publication-type="journal" id="ptr6893-cit-0019">
<string-name>
<surname>Fitzgerald</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Heinrich</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Booker</surname>, <given-names>A.</given-names>
</string-name> (<year>2020</year>). <article-title>Medicinal plant analysis: A historical and regional discussion of emergent complex techniques</article-title>. <source xml:lang="en">Frontiers in Pharmacology</source>, <volume>10</volume>, <fpage>1480</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2019.01480</pub-id>
<pub-id pub-id-type="pmid">31998121</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0020"><mixed-citation publication-type="journal" id="ptr6893-cit-0020">
<string-name>
<surname>Gianella</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Snapp</surname>, <given-names>E. L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Levy</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>An in vitro compartmentalization&#x02010;based method for the selection of bond&#x02010;forming enzymes from large libraries</article-title>. <source xml:lang="en">Biotechnology and Bioengineering</source>, <volume>113</volume>(<issue>8</issue>), <fpage>1647</fpage>&#x02013;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">26806853</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0021"><mixed-citation publication-type="journal" id="ptr6893-cit-0021">
<string-name>
<surname>Glatthaar&#x02010;Saalm&#x000fc;ller</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Sacher</surname>, <given-names>F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Esperester</surname>, <given-names>A.</given-names>
</string-name> (<year>2001</year>). <article-title>Antiviral activity of an extract derived from roots of <italic>Eleutherococcus senticosus</italic>
</article-title>. <source xml:lang="en">Antiviral Research</source>, <volume>50</volume>(<issue>3</issue>), <fpage>223</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-3542(01)00143-7</pub-id>
<pub-id pub-id-type="pmid">11397509</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0022"><mixed-citation publication-type="journal" id="ptr6893-cit-0022">
<string-name>
<surname>Ho</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hsiang</surname>, <given-names>C.</given-names>
</string-name> (<year>2007</year>). <article-title>Emodin blocks the SARS coronavirus spike protein and angiotensin&#x02010;converting enzyme 2 interaction</article-title>. <source xml:lang="en">Antiviral Research</source>, <volume>74</volume>(<issue>2</issue>), <fpage>92</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2006.04.014</pub-id>
<pub-id pub-id-type="pmid">16730806</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0023"><mixed-citation publication-type="journal" id="ptr6893-cit-0023">
<string-name>
<surname>Hoever</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Baltina</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Michaelis</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kondratenko</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Baltina</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Tolstikov</surname>, <given-names>G. A.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Cinatl</surname>, <given-names>J.</given-names>
</string-name> (<year>2005</year>). <article-title>Antiviral activity of glycyrrhizic acid derivatives against SARS&#x02212;coronavirus</article-title>. <source xml:lang="en">Journal of Medicinal Chemistry</source>, <volume>48</volume>(<issue>4</issue>), <fpage>1256</fpage>&#x02013;<lpage>1259</lpage>. <pub-id pub-id-type="doi">10.1021/jm0493008</pub-id>
<pub-id pub-id-type="pmid">15715493</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0024"><mixed-citation publication-type="journal" id="ptr6893-cit-0024">
<string-name>
<surname>Hui</surname>, <given-names>D. S.</given-names>
</string-name>, <string-name>
<surname>I Azhar</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Madani</surname>, <given-names>T. A.</given-names>
</string-name>, <string-name>
<surname>Ntoumi</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Kock</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Dar</surname>, <given-names>O.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Petersen</surname>, <given-names>E.</given-names>
</string-name> (<year>2020</year>). <article-title>The continuing 2019&#x02010;nCoV epidemic threat of novel coronaviruses to global health&#x02014;The latest 2019 novel coronavirus outbreak in Wuhan, China</article-title>. <source xml:lang="en">International Journal of Infectious Diseases</source>, <volume>91</volume>, <fpage>264</fpage>&#x02013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.01.009</pub-id>
<pub-id pub-id-type="pmid">31953166</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0025"><mixed-citation publication-type="journal" id="ptr6893-cit-0025">
<string-name>
<surname>Ichikawa</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Matsuda</surname>, <given-names>A.</given-names>
</string-name> (<year>2007</year>). <article-title>Nucleoside natural products and related analogs with potential therapeutic properties as antibacterial and antiviral agents</article-title>. <source xml:lang="en">Expert Opinion on Therapeutic Patents</source>, <volume>17</volume>(<issue>5</issue>), <fpage>487</fpage>&#x02013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1517/13543776.17.5.487</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0026"><mixed-citation publication-type="journal" id="ptr6893-cit-0026">
<string-name>
<surname>Islam</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<surname>Sarkar</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Kersh</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Jamaddar</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Uddin</surname>, <given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Shilpi</surname>, <given-names>J. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Mubarak</surname>, <given-names>M. S.</given-names>
</string-name> (<year>2020</year>). <article-title>Natural products and their derivatives against coronavirus: A review of the non&#x02010;clinical and pre&#x02010;clinical data</article-title>. <source xml:lang="en">Phytotherapy Research</source>. <pub-id pub-id-type="doi">10.1002/ptr.6700</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0027"><mixed-citation publication-type="journal" id="ptr6893-cit-0027">
<string-name>
<surname>Jang</surname>, <given-names>K.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kang</surname>, <given-names>D. Y.</given-names>
</string-name>, <string-name>
<surname>Sp</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>Y. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kim</surname>, <given-names>D.&#x02010;E.</given-names>
</string-name> (<year>2020</year>). <article-title>A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA</article-title>. <source xml:lang="en">Scientific Reports</source>, <volume>10</volume>(<issue>1</issue>), <elocation-id>4481</elocation-id>
<pub-id pub-id-type="doi">10.1038/s41598-020-61432-1</pub-id>
<pub-id pub-id-type="pmid">32161317</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0028"><mixed-citation publication-type="journal" id="ptr6893-cit-0028">
<string-name>
<surname>Jo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shin</surname>, <given-names>D. H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kim</surname>, <given-names>M.&#x02010;S.</given-names>
</string-name> (<year>2019</year>). <article-title>Characteristics of flavonoids as potent MERS&#x02010;CoV 3C&#x02010;like protease inhibitors</article-title>. <source xml:lang="en">Chemical Biology &#x00026; Drug Design</source>, <volume>94</volume>(<issue>6</issue>), <fpage>2023</fpage>&#x02013;<lpage>2030</lpage>. <pub-id pub-id-type="doi">10.1111/cbdd.13604</pub-id>
<pub-id pub-id-type="pmid">31436895</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0029"><mixed-citation publication-type="journal" id="ptr6893-cit-0029">
<string-name>
<surname>Jo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shin</surname>, <given-names>D. H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kim</surname>, <given-names>M.&#x02010;S.</given-names>
</string-name> (<year>2020</year>). <article-title>Inhibition of SARS&#x02010;CoV 3CL protease by flavonoids</article-title>. <source xml:lang="en">Journal of Enzyme Inhibition and Medicinal Chemistry</source>, <volume>35</volume>(<issue>1</issue>), <fpage>145</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1080/14756366.2019.1690480</pub-id>
<pub-id pub-id-type="pmid">31724441</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0030"><mixed-citation publication-type="journal" id="ptr6893-cit-0030">
<string-name>
<surname>Joshi</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Panda</surname>, <given-names>S. K.</given-names>
</string-name>, <string-name>
<surname>Jouneghani</surname>, <given-names>R. S.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Parajuli</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Leyssen</surname>, <given-names>P.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Luyten</surname>, <given-names>W.</given-names>
</string-name> (<year>2020</year>). <article-title>Antibacterial, antifungal, antiviral, and anthelmintic activities of medicinal plants of Nepal selected based on ethnobotanical evidence</article-title>. <source xml:lang="en">Evidence&#x02010;Based Complementary and Alternative Medicine</source>, <volume>2020</volume>, <elocation-id>1043471</elocation-id>
<pub-id pub-id-type="doi">10.1155/2020/1043471</pub-id>
<pub-id pub-id-type="pmid">32382275</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0031"><mixed-citation publication-type="journal" id="ptr6893-cit-0031">
<string-name>
<surname>Khaerunnisa</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kurniawan</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Awaluddin</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Suhartati</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Soetjipto</surname>, <given-names>S.</given-names>
</string-name> (<year>2020</year>). <article-title>
<italic>Potential inhibitor of COVID&#x02010;19 main protease (M</italic>
<sup><italic>pro</italic></sup>
<italic>) from several medicinal plant compounds by molecular docking study</italic>
</article-title> [preprint]. <source xml:lang="en">Medicine &#x00026; Pharmacology</source>. <pub-id pub-id-type="doi">10.20944/preprints202003.0226.v1</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0032"><mixed-citation publication-type="journal" id="ptr6893-cit-0032">
<string-name>
<surname>Kim</surname>, <given-names>H.&#x02010;Y.</given-names>
</string-name>, <string-name>
<surname>Shin</surname>, <given-names>H.&#x02010;S.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Yun</surname>, <given-names>Y. G.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Kim</surname>, <given-names>K.</given-names>
</string-name> (<year>2008</year>). <article-title>In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex</article-title>. <source xml:lang="en">Journal of Clinical Virology</source>, <volume>41</volume>(<issue>2</issue>), <fpage>122</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2007.10.011</pub-id>
<pub-id pub-id-type="pmid">18036887</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0033"><mixed-citation publication-type="journal" id="ptr6893-cit-0033">
<string-name>
<surname>Kitazato</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kobayashi</surname>, <given-names>N.</given-names>
</string-name> (<year>2007</year>). <article-title>Viral infectious disease and natural products with antiviral activity</article-title>. <source xml:lang="en">Drug Discoveries &#x00026; Therapeutics</source>, <volume>1</volume>(<issue>1</issue>), <fpage>14</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">22504360</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0034"><mixed-citation publication-type="journal" id="ptr6893-cit-0034">
<string-name>
<surname>Lau</surname>, <given-names>K.&#x02010;M.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>K.&#x02010;M.</given-names>
</string-name>, <string-name>
<surname>Koon</surname>, <given-names>C.&#x02010;M.</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>, <given-names>C. S.&#x02010;F.</given-names>
</string-name>, <string-name>
<surname>Lau</surname>, <given-names>C.&#x02010;P.</given-names>
</string-name>, <string-name>
<surname>Ho</surname>, <given-names>H.&#x02010;M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Fung</surname>, <given-names>K.&#x02010;P.</given-names>
</string-name> (<year>2008</year>). <article-title>Immunomodulatory and anti&#x02010;SARS activities of <italic>Houttuynia cordata</italic>
</article-title>. <source xml:lang="en">Journal of Ethnopharmacology</source>, <volume>118</volume>(<issue>1</issue>), <fpage>79</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.03.018</pub-id>
<pub-id pub-id-type="pmid">18479853</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0035"><mixed-citation publication-type="journal" id="ptr6893-cit-0035">
<string-name>
<surname>Li</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Guo</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>L.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Xiao</surname>, <given-names>P.</given-names>
</string-name> (<year>2005</year>). <article-title>Identification of natural compounds with antiviral activities against SARS&#x02010;associated coronavirus</article-title>. <source xml:lang="en">Antiviral Research</source>, <volume>67</volume>(<issue>1</issue>), <fpage>18</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2005.02.007</pub-id>
<pub-id pub-id-type="pmid">15885816</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0036"><mixed-citation publication-type="journal" id="ptr6893-cit-0036">
<string-name>
<surname>Liao</surname>, <given-names>L. E.</given-names>
</string-name>, <string-name>
<surname>Kowal</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Cardenas</surname>, <given-names>D. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Beauchemin</surname>, <given-names>C. A. A.</given-names>
</string-name> (<year>2017</year>). <article-title>Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors</article-title>. <source xml:lang="en">PLoS One</source>, <volume>12</volume>(<issue>8</issue>), <elocation-id>e0183621</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0183621</pub-id>
<pub-id pub-id-type="pmid">28837615</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0037"><mixed-citation publication-type="journal" id="ptr6893-cit-0037">
<string-name>
<surname>Lin</surname>, <given-names>C.&#x02010;W.</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>, <given-names>F.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Tsai</surname>, <given-names>C.&#x02010;H.</given-names>
</string-name>, <string-name>
<surname>Lai</surname>, <given-names>C.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Wan</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ho</surname>, <given-names>T.&#x02010;Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Chao</surname>, <given-names>P.&#x02010;D. L.</given-names>
</string-name> (<year>2005</year>). <article-title>Anti&#x02010;SARS coronavirus 3C&#x02010;like protease effects of Isatis indigotica root and plant&#x02010;derived phenolic compounds</article-title>. <source xml:lang="en">Antiviral Research</source>, <volume>68</volume>(<issue>1</issue>), <fpage>36</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">16115693</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0038"><mixed-citation publication-type="journal" id="ptr6893-cit-0038">
<string-name>
<surname>Lin</surname>, <given-names>Y.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>Y.&#x02010;C.</given-names>
</string-name>, <string-name>
<surname>Hsiao</surname>, <given-names>N.&#x02010;W.</given-names>
</string-name>, <string-name>
<surname>Hsieh</surname>, <given-names>J.&#x02010;L.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>C.&#x02010;Y.</given-names>
</string-name>, <string-name>
<surname>Kung</surname>, <given-names>S.&#x02010;H.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Lin</surname>, <given-names>C.&#x02010;W.</given-names>
</string-name> (<year>2012</year>). <article-title>Fisetin and rutin as 3C protease inhibitors of enterovirus A71</article-title>. <source xml:lang="en">Journal of Virological Methods</source>, <volume>182</volume>(<issue>1&#x02013;2</issue>), <fpage>93</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2012.03.020</pub-id>
<pub-id pub-id-type="pmid">22465253</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0039"><mixed-citation publication-type="journal" id="ptr6893-cit-0039">
<string-name>
<surname>Liu</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Xiong</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Xiang</surname>, <given-names>Y.&#x02010;F.</given-names>
</string-name>, <string-name>
<surname>Guo</surname>, <given-names>C.&#x02010;W.</given-names>
</string-name>, <string-name>
<surname>Ge</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>C.&#x02010;R.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Kitazato</surname>, <given-names>K.</given-names>
</string-name> (<year>2011</year>). <article-title>Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus</article-title>. <source xml:lang="en">Archives of Virology</source>, <volume>156</volume>(<issue>8</issue>), <fpage>1359</fpage>&#x02013;<lpage>1369</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-011-0989-9</pub-id>
<pub-id pub-id-type="pmid">21479599</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0040"><mixed-citation publication-type="journal" id="ptr6893-cit-0040">
<string-name>
<surname>Liu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Zu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Gao</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Min</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Zhuo</surname>, <given-names>W.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Liu</surname>, <given-names>A.</given-names>
</string-name> (<year>2018</year>). <article-title>Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines</article-title>. <source xml:lang="en">BMC Complementary and Alternative Medicine</source>, <volume>18</volume>(<issue>1</issue>), <elocation-id>102</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12906-018-2173-1</pub-id>
<pub-id pub-id-type="pmid">29558938</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0041"><mixed-citation publication-type="journal" id="ptr6893-cit-0041">
<string-name>
<surname>Lloyd</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Russell</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Blanes</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Doble</surname>, <given-names>P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Roux</surname>, <given-names>C.</given-names>
</string-name> (<year>2013</year>). <article-title>Lab&#x02010;on&#x02010;a&#x02010;chip screening of methamphetamine and pseudoephedrine in samples from clandestine laboratories</article-title>. <source xml:lang="en">Forensic Science International</source>, <volume>228</volume>(<issue>1</issue>), <fpage>8</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.forsciint.2013.01.036</pub-id>
<pub-id pub-id-type="pmid">23597732</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0042"><mixed-citation publication-type="journal" id="ptr6893-cit-0042">
<string-name>
<surname>Lu</surname>, <given-names>H.</given-names>
</string-name> (<year>2020</year>). <article-title>Drug treatment options for the 2019&#x02010;new coronavirus (2019&#x02010;nCoV)</article-title>. <source xml:lang="en">BioScience Trends</source>, <volume>14</volume>(<issue>1</issue>), <fpage>69</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.5582/bst.2020.01020</pub-id>
<pub-id pub-id-type="pmid">31996494</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0043"><mixed-citation publication-type="journal" id="ptr6893-cit-0043">
<string-name>
<surname>Luo</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Tang</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Shang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Liang</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>, <given-names>N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Liu</surname>, <given-names>J.</given-names>
</string-name> (<year>2020</year>). <article-title>Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID&#x02010;19)? A review of historical classics, research evidence and current prevention programs</article-title>. <source xml:lang="en">Chinese Journal of Integrative Medicine</source>, <volume>26</volume>(<issue>4</issue>), <fpage>243</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s11655-020-3192-6</pub-id>
<pub-id pub-id-type="pmid">32065348</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0044"><mixed-citation publication-type="journal" id="ptr6893-cit-0044">
<string-name>
<surname>Malik</surname>, <given-names>Y. S.</given-names>
</string-name>, <string-name>
<surname>Sircar</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bhat</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sharun</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Dhama</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Dadar</surname>, <given-names>M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Chaicumpa</surname>, <given-names>W.</given-names>
</string-name> (<year>2020</year>). <article-title>Emerging novel coronavirus (2019&#x02010;nCoV)&#x02014;Current scenario, evolutionary perspective based on genome analysis and recent developments</article-title>. <source xml:lang="en">Veterinary Quarterly</source>, <volume>40</volume>(<issue>1</issue>), <fpage>68</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1080/01652176.2020.1727993</pub-id>
<pub-id pub-id-type="pmid">32036774</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0045"><mixed-citation publication-type="journal" id="ptr6893-cit-0045">
<string-name>
<surname>Miki</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Nagai</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Tsujimura</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Koyama</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Kinoshita</surname>, <given-names>K.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Takahashi</surname>, <given-names>K.</given-names>
</string-name> (<year>2007</year>). <article-title>Anti&#x02010;influenza virus activity of biflavonoids</article-title>. <source xml:lang="en">Bioorganic &#x00026; Medicinal Chemistry Letters</source>, <volume>17</volume>(<issue>3</issue>), <fpage>772</fpage>&#x02013;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2006.10.075</pub-id>
<pub-id pub-id-type="pmid">17110111</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0046"><mixed-citation publication-type="journal" id="ptr6893-cit-0046">
<string-name>
<surname>Mishra</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pandey</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Manvati</surname>, <given-names>S.</given-names>
</string-name> (<year>2020</year>). <article-title>Coumarin: An emerging antiviral agent</article-title>. <source xml:lang="en">Heliyon</source>, <volume>6</volume>(<issue>1</issue>), <elocation-id>e03217</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03217</pub-id>
<pub-id pub-id-type="pmid">32042967</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0047"><mixed-citation publication-type="journal" id="ptr6893-cit-0047">
<string-name>
<surname>Mishra</surname>, <given-names>U. N.</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>, <given-names>M. V.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Prasad</surname>, <given-names>D. T.</given-names>
</string-name> (<year>2020</year>). <article-title>Plant serine protease inhibitor (SPI): A potent player with bactericidal, fungicidal, nematicidal and antiviral properties</article-title>. <source xml:lang="en">International Journal of Chemical Studies</source>, <volume>8</volume>(<issue>1</issue>), <fpage>2985</fpage>&#x02013;<lpage>2993</lpage>. <pub-id pub-id-type="doi">10.22271/chemi.2020.v8.i1at.8724</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0048"><mixed-citation publication-type="journal" id="ptr6893-cit-0048">
<string-name>
<surname>Muchtaridi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sugijanto</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mohd Gazzali</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Wahab</surname>, <given-names>H. A.</given-names>
</string-name> (<year>2020</year>). <article-title>Anti&#x02010;neuraminidase bioactives from Manggis Hutan (Garcinia celebica L.) leaves: Partial purification and molecular characterization</article-title>. <source xml:lang="en">Molecules</source>, <volume>25</volume>(<issue>4</issue>), <fpage>821</fpage>
<pub-id pub-id-type="doi">10.3390/molecules25040821</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0049"><mixed-citation publication-type="journal" id="ptr6893-cit-0049">
<string-name>
<surname>Mukhtar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Arshad</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pomerantz</surname>, <given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Wigdahl</surname>, <given-names>B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Parveen</surname>, <given-names>Z.</given-names>
</string-name> (<year>2008</year>). <article-title>Antiviral potentials of medicinal plants</article-title>. <source xml:lang="en">Virus Research</source>, <volume>131</volume>(<issue>2</issue>), <fpage>111</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2007.09.008</pub-id>
<pub-id pub-id-type="pmid">17981353</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0050"><mixed-citation publication-type="journal" id="ptr6893-cit-0050">
<string-name>
<surname>Nagai</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Miyaichi</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Tomimori</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Yamada</surname>, <given-names>H.</given-names>
</string-name> (<year>1992</year>). <article-title>In vivo anti&#x02010;influenza virus activity of plant flavonoids possessing inhibitory activity for influenza virus sialidase</article-title>. <source xml:lang="en">Antiviral Research</source>, <volume>19</volume>(<issue>3</issue>), <fpage>207</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/0166-3542(92)90080-O</pub-id>
<pub-id pub-id-type="pmid">1444327</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0052"><mixed-citation publication-type="journal" id="ptr6893-cit-0052">
<string-name>
<surname>Ogbole</surname>, <given-names>O. O.</given-names>
</string-name>, <string-name>
<surname>Akinleye</surname>, <given-names>T. E.</given-names>
</string-name>, <string-name>
<surname>Segun</surname>, <given-names>P. A.</given-names>
</string-name>, <string-name>
<surname>Faleye</surname>, <given-names>T. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Adeniji</surname>, <given-names>A. J.</given-names>
</string-name> (<year>2018</year>). <article-title>In vitro antiviral activity of twenty&#x02010;seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses</article-title>. <source xml:lang="en">Virology Journal</source>, <volume>15</volume>(<issue>1</issue>), <elocation-id>110</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12985-018-1022-7</pub-id>
<pub-id pub-id-type="pmid">30021589</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0053"><mixed-citation publication-type="journal" id="ptr6893-cit-0053">
<string-name>
<surname>Ogbole</surname>, <given-names>O. O.</given-names>
</string-name>, <string-name>
<surname>Segun</surname>, <given-names>P. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Adeniji</surname>, <given-names>A. J.</given-names>
</string-name> (<year>2017</year>). <article-title>In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts</article-title>. <source xml:lang="en">BMC Complementary and Alternative Medicine</source>, <volume>17</volume>(<issue>1</issue>), <elocation-id>494</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12906-017-2005-8</pub-id>
<pub-id pub-id-type="pmid">29166892</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0054"><mixed-citation publication-type="journal" id="ptr6893-cit-0054">
<string-name>
<surname>Orhan</surname>, <given-names>I. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Senol Deniz</surname>, <given-names>F. S.</given-names>
</string-name> (<year>2020</year>). <article-title>Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS&#x02010;CoV&#x02010;2?</article-title>
<source xml:lang="en">Natural Products and Bioprospecting</source>, <volume>10</volume>, <fpage>171</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1007/s13659-020-00250-4</pub-id>
<pub-id pub-id-type="pmid">32529545</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0055"><mixed-citation publication-type="journal" id="ptr6893-cit-0055">
<string-name>
<surname>Park</surname>, <given-names>J.&#x02010;Y.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>, <given-names>H.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Jeong</surname>, <given-names>H. J.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y. M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ryu</surname>, <given-names>Y. B.</given-names>
</string-name> (<year>2013</year>). <article-title>Dieckol, a SARS&#x02010;CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava</article-title>. <source xml:lang="en">Bioorganic &#x00026; Medicinal Chemistry</source>, <volume>21</volume>(<issue>13</issue>), <fpage>3730</fpage>&#x02013;<lpage>3737</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2013.04.026</pub-id>
<pub-id pub-id-type="pmid">23647823</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0056"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0056">
<string-name>
<surname>Peng</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Shi</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Mu</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Yang</surname>, <given-names>Y.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Zhu</surname>, <given-names>Weiliang</given-names>
</string-name>. (<year>2020</year>). <italic>Exploring the binding mechanism and accessible angle of SARS&#x02010;CoV&#x02010;2 spike and ACE2 by molecular dynamics simulation and free energy calculation</italic> Retrieved from <pub-id pub-id-type="doi">10.26434/chemrxiv.11877492.v1</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0057"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0057">
<string-name>
<surname>Pe&#x00161;i&#x00107;</surname>, <given-names>M.</given-names>
</string-name> (<year>2015</year>). <italic>Development of natural product drugs in a sustainable manner</italic> Brief for GSDR 2015. Retrieved from <ext-link ext-link-type="uri" xlink:href="https://sustainabledevelopment.un.org/content/documents/6544118_Pesic_Development%20of%20natural%20product%20drugs%20in%20a%20%20sustainable%20manner.pdf">https://sustainabledevelopment.un.org/content/documents/6544118_Pesic_Development%20of%20natural%20product%20drugs%20in%20a%20%20sustainable%20manner.pdf</ext-link>
</mixed-citation></ref><ref id="ptr6893-bib-0058"><mixed-citation publication-type="journal" id="ptr6893-cit-0058">
<string-name>
<surname>Pour</surname>, <given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Fakhri</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Asgary</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Farzaei</surname>, <given-names>M. H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Echeverr&#x000ed;a</surname>, <given-names>J.</given-names>
</string-name> (<year>2019</year>). <article-title>The signaling pathways, and therapeutic targets of antiviral agents: Focusing on the antiviral approaches and clinical perspectives of Anthocyanins in the Management of Viral Diseases</article-title>. <source xml:lang="en">Frontiers in Pharmacology</source>, <volume>10</volume>, <fpage>1</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.01207</pub-id>
<pub-id pub-id-type="pmid">30728774</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0060"><mixed-citation publication-type="journal" id="ptr6893-cit-0060">
<string-name>
<surname>Rajbhandari</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Wegner</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>J&#x000fc;lich</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sch&#x000f6;pke</surname>, <given-names>T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Mentel</surname>, <given-names>R.</given-names>
</string-name> (<year>2001</year>). <article-title>Screening of Nepalese medicinal plants for antiviral activity</article-title>. <source xml:lang="en">Journal of Ethnopharmacology</source>, <volume>74</volume>(<issue>3</issue>), <fpage>251</fpage>&#x02013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-8741(00)00374-3</pub-id>
<pub-id pub-id-type="pmid">11274826</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0061"><mixed-citation publication-type="journal" id="ptr6893-cit-0061">
<string-name>
<surname>Rebensburg</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Helfer</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Koppensteiner</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Eberle</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Schindler</surname>, <given-names>M.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Brack&#x02010;Werner</surname>, <given-names>R.</given-names>
</string-name> (<year>2016</year>). <article-title>Potent in vitro antiviral activity of <italic>Cistus incanus</italic> extract against HIV and Filoviruses targets viral envelope proteins</article-title>. <source xml:lang="en">Scientific Reports</source>, <volume>6</volume>(<issue>1</issue>), <elocation-id>20394</elocation-id>
<pub-id pub-id-type="doi">10.1038/srep20394</pub-id>
<pub-id pub-id-type="pmid">26833261</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0051"><mixed-citation publication-type="journal" id="ptr6893-cit-0051">Redeploying plant defences. (<year>2020</year>). <italic>Nature Plants</italic>, <volume>6</volume>(3), <fpage>177</fpage>
<pub-id pub-id-type="doi">10.1038/s41477-020-0628-0</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0062"><mixed-citation publication-type="journal" id="ptr6893-cit-0062">
<string-name>
<surname>Robinson</surname>, <given-names>W. E.</given-names>
</string-name>, <string-name>
<surname>Reinecke</surname>, <given-names>M. G.</given-names>
</string-name>, <string-name>
<surname>Abdel&#x02010;Malek</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Jia</surname>, <given-names>Q.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Chow</surname>, <given-names>S. A.</given-names>
</string-name> (<year>1996</year>). <article-title>Inhibitors of HIV&#x02010;1 replication that inhibit HIV integrase</article-title>. <source xml:lang="en">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>93</volume>(<issue>13</issue>), <fpage>6326</fpage>&#x02013;<lpage>6331</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.13.6326</pub-id>
<pub-id pub-id-type="pmid">8692814</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0063"><mixed-citation publication-type="journal" id="ptr6893-cit-0063">
<string-name>
<surname>Rodr&#x000ed;guez&#x02010;Morales</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>MacGregor</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Kanagarajah</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Patel</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Schlagenhauf</surname>, <given-names>P.</given-names>
</string-name> (<year>2020</year>). <article-title>Going global &#x02013; Travel and the 2019 novel coronavirus</article-title>. <source xml:lang="en">Travel Medicine and Infectious Disease</source>, <volume>33</volume>, <elocation-id>101578</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101578</pub-id>
<pub-id pub-id-type="pmid">32044389</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0064"><mixed-citation publication-type="journal" id="ptr6893-cit-0064">
<string-name>
<surname>Rothe</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Surjadi</surname>, <given-names>R. N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Power</surname>, <given-names>B. E.</given-names>
</string-name> (<year>2006</year>). <article-title>Novel proteins in emulsions using in vitro compartmentalization</article-title>. <source xml:lang="en">Trends in Biotechnology</source>, <volume>24</volume>(<issue>12</issue>), <fpage>587</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2006.10.007</pub-id>
<pub-id pub-id-type="pmid">17055094</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0065"><mixed-citation publication-type="journal" id="ptr6893-cit-0065">
<string-name>
<surname>Ryu</surname>, <given-names>Y. B.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>S.&#x02010;J.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y. M.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>J.&#x02010;Y.</given-names>
</string-name>, <string-name>
<surname>Seo</surname>, <given-names>W. D.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>J. S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Lee</surname>, <given-names>W. S.</given-names>
</string-name> (<year>2010</year>). <article-title>SARS&#x02010;CoV 3CL<sup>pro</sup> inhibitory effects of quinone&#x02010;methide triterpenes from Tripterygium regelii</article-title>. <source xml:lang="en">Bioorganic &#x00026; Medicinal Chemistry Letters</source>, <volume>20</volume>(<issue>6</issue>), <fpage>1873</fpage>&#x02013;<lpage>1876</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.01.152</pub-id>
<pub-id pub-id-type="pmid">20167482</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0066"><mixed-citation publication-type="journal" id="ptr6893-cit-0066">
<string-name>
<surname>Sornpet</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Potha</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Tragoolpua</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Pringproa</surname>, <given-names>K.</given-names>
</string-name> (<year>2017</year>). <article-title>Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus</article-title>. <source xml:lang="en">Asian Pacific Journal of Tropical Medicine</source>, <volume>10</volume>(<issue>9</issue>), <fpage>871</fpage>&#x02013;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1016/j.apjtm.2017.08.010</pub-id>
<pub-id pub-id-type="pmid">29080615</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0068"><mixed-citation publication-type="journal" id="ptr6893-cit-0068">
<string-name>
<surname>Tiwari</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Darmani</surname>, <given-names>N. A.</given-names>
</string-name>, <string-name>
<surname>Yue</surname>, <given-names>B. Y. J. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Shukla</surname>, <given-names>D.</given-names>
</string-name> (<year>2010</year>). <article-title>In vitro antiviral activity of neem (<italic>Azardirachta indica</italic> L.) bark extract against herpes simplex virus type&#x02010;1 infection</article-title>. <source xml:lang="en">Phytotherapy Research</source>, <volume>24</volume>(<issue>8</issue>), <fpage>1132</fpage>&#x02013;<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.3085</pub-id>
<pub-id pub-id-type="pmid">20041417</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0069"><mixed-citation publication-type="journal" id="ptr6893-cit-0069">
<string-name>
<surname>Tomei</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Altamura</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bartholomew</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Biroccio</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ceccacci</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Pacini</surname>, <given-names>L.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Migliaccio</surname>, <given-names>G.</given-names>
</string-name> (<year>2003</year>). <article-title>Mechanism of action and antiviral activity of benzimidazole&#x02010;based allosteric inhibitors of the hepatitis C virus RNA&#x02010;dependent RNA polymerase</article-title>. <source xml:lang="en">Journal of Virology</source>, <volume>77</volume>(<issue>24</issue>), <fpage>13225</fpage>&#x02013;<lpage>13231</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.77.24.13225-13231.2003</pub-id>
<pub-id pub-id-type="pmid">14645579</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0070"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0070">
<string-name>
<surname>Utomo</surname>, <given-names>R. Y.</given-names>
</string-name>, <string-name>
<surname>Ikawati</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Meiyanto</surname>, <given-names>E.</given-names>
</string-name> (<year>2020</year>). <italic>Revealing the potency of citrus and galangal constituents to halt SARS&#x02010;CoV&#x02010;2 infection</italic> Retrieved from <pub-id pub-id-type="doi">10.20944/preprints202003.0214.v1</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0071"><mixed-citation publication-type="journal" id="ptr6893-cit-0071">
<string-name>
<surname>Vimalanathan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ignacimuthu</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hudson</surname>, <given-names>J. B.</given-names>
</string-name> (<year>2009</year>). <article-title>Medicinal plants of Tamil Nadu (Southern India) are a rich source of antiviral activities</article-title>. <source xml:lang="en">Pharmaceutical Biology</source>, <volume>47</volume>(<issue>5</issue>), <fpage>422</fpage>&#x02013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1080/13880200902800196</pub-id>
</mixed-citation></ref><ref id="ptr6893-bib-0072"><mixed-citation publication-type="journal" id="ptr6893-cit-0072">
<string-name>
<surname>Webster</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Taschereau</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Jurgens</surname>, <given-names>T.</given-names>
</string-name> (<year>2006</year>). <article-title>Immunostimulant properties of <italic>Heracleum maximum</italic> Bartr</article-title>. <source xml:lang="en">Journal of Ethnopharmacology</source>, <volume>106</volume>(<issue>3</issue>), <fpage>360</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.01.018</pub-id>
<pub-id pub-id-type="pmid">16504434</pub-id></mixed-citation></ref><ref id="ptr6893-bib-0073"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0073">
<collab collab-type="authors">WHO</collab>
. (<year>2020a</year>). <italic>Advice for public</italic> Retrieved from <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public</ext-link>
</mixed-citation></ref><ref id="ptr6893-bib-0074"><mixed-citation publication-type="miscellaneous" id="ptr6893-cit-0074">
<collab collab-type="authors">WHO</collab>
. (<year>2020b</year>). <italic>Report of the WHO&#x02010;China Joint Mission on Coronavirus Disease 2019 (COVID&#x02010;19)</italic> Retrieved from <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19">https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19</ext-link>)</mixed-citation></ref><ref id="ptr6893-bib-0075"><mixed-citation publication-type="journal" id="ptr6893-cit-0075">
<string-name>
<surname>Xian</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Bian</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>Z.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Xu</surname>, <given-names>H.</given-names>
</string-name> (<year>2020</year>). <article-title>Bioactive natural compounds against human coronaviruses: A review and perspective</article-title>. <source xml:lang="en">Acta Pharmaceutica Sinica B</source>, <volume>10</volume>, <fpage>1163</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2020.06.002</pub-id>
<pub-id pub-id-type="pmid">32834947</pub-id></mixed-citation></ref></ref-list></back></article>